(All fields required)
Please enter a valid email.
Please enter your name.
What is : (So we know you are human.)
Please supply the correct answer.
The Division of Pulmonary Medicine is home to specialists with a wide variety of backgrounds and areas of focus. As a team, this diversity makes us better prepared to care for your child’s unique needs. Learn more about our faculty, fellows and staff.
Raouf S. Amin, MD Director, Division of Pulmonary Medicine 513-636-6771 firstname.lastname@example.org
Director, Division of Pulmonary Medicine
The Hubert and Dorothy Campbell Chair of Pediatric Pulmonology
Professor, UC Department of Pediatrics
Chronic respiratory failure; sleep disorders in children
Raouf S. Amin, MD, is the director of the Division of Pulmonary Medicine at Cincinnati Children's Hospital Medical Center and a professor for the UC Department of Pediatrics. He graduated from the University of Ain Shams in Cairo Egypt in 1977. Dr. Amin received clinical training in the United Kingdom and the United States. He completed a pulmonary fellowship at Cincinnati Children's Hospital Medical Center in 1993. His research focus is on cardiovascular morbidity of sleep disordered breathing in children. He has several funded protocols from the National Institute of Health.
MD: Aim Shams University, Cairo Egypt, 1978.
Residency: Pediatrics; Michigan State University, Flint, MI.
Certification: Pediatrics 1990; Pediatric Pulmonary Medicine 1994; Sleep Medicine, 1995.
Clancy JP, Rowe SM, Accurso FJ, Aitken ML, Amin RS, Ashlock MA, Ballmann M, Boyle MP, Bronsveld I, Campbell PW, Deboeck K, Donaldson SH, Dorkin HL, Dunitz JM, Durie PR, Jain M, Leonard A, McCoy KS, Moss RB, Pilewski JM, Rosenbluth DB, Rubenstein RC, Schechter MS, Botfield M, Ordoñez CL, Spencer-Green GT, Vernillet L, Wisseh S, Yen K, Konstan MW. Results of a phase IIa study of VX-809, an investigational CFTR corrector compound, in subjects with cystic fibrosis homozygous for the F508del-CFTR mutation. Thorax. 2012 Jan;67(1):12-8.
Sung V, Beebe DW, Vandyke R, Fenchel MC, Crimmins NA, Kirk S, Hiscock H, Amin R, Wake M. Does sleep duration predict metabolic risk in obese adolescents attending tertiary services? A cross-sectional study. Sleep. 2011 Jul 1;34(7):891-8.
Sawnani H, Murugappan S, Gutmark E, Donnelly LF, Amin R, Mylavarapu G, Mihaescu M, Khosla S, Kalra M. Influence of gender on pharyngeal airway length in obese adolescents. Ann Otol Rhinol Laryngol. 2010 Dec;119(12):842-7.
Beebe DW, Ris MD, Kramer ME, Long E, Amin R. The association between sleep disordered breathing, academic grades, and cognitive and behavioral functioning among overweight subjects during middle to late childhood. Sleep. 2010 Nov 1;33(11):1447-56.
Beebe DW, Rose D, Amin R. Attention, learning, and arousal of experimentally sleep-restricted adolescents in a simulated classroom.J Adolesc Health. 2010 Nov;47(5):523-5.
McPhail GL, Weiland J, Acton JD, Ednick M, Chima A, VanDyke R, Fenchel MC, Amin RS, Seid M. Improving evidence-based care in cystic fibrosis through quality improvement. Arch Pediatr Adolesc Med. 2010 Oct;164(10):957-60.
McPhail GL, Ednick MD, Fenchel MC, VanDyke R, Chima A, Amin RS, Seid M. Improving follow-up in hospitalised children. Qual Saf Health Care. 2010 Oct;19(5):e35.
Ednick M, Cohen AP, McPhail GL, Beebe D, Simakajornboon N, Amin RS. A review of the effects of sleep during the first year of life on cognitive, psychomotor, and temperament development. Sleep. 2009 Nov 1;32(11):1449-58.
Ednick M, Tinkle BT, Phromchairak J, Egelhoff J, Amin R, Simakajornboon N. Sleep-related respiratory abnormalities and arousal pattern in achondroplasia during early infancy. J Pediatr. 2009 Oct;155(4):510-5.
McConnell K, Somers VK, Kimball T, Daniels S, VanDyke R, Fenchel M, Cohen A, Willging P, Shamsuzzaman A, Amin R. Baroreflex gain in children with obstructive sleep apnea. Am J Respir Crit Care Med. 2009 Jul 1;180(1):42-8.
Dan Benscoter, DO 513-636-6771
Assistant Professor, UC Department of Pediatrics
Thomas F. Boat, MD Director, CFWELL, Division of Pulmonary Medicine 513-636-6771 email@example.com
Director, CFWELL, Division of Pulmonary Medicine
Pediatric respiratory diseases; Cystic Fibrosis.
MD: University of Iowa, Iowa City, IA, 1966.
Residency: Pediatrics, University of Minnesota, Minneapolis, MN, 1968.
Certification: Pediatrics, 1972.
Boat TF, Wu J, IOM Report. Mental disorders and disabilities among low-income children. Washington (DC):National Academies Press (US);2015.
Boat TF. Improving lifetime health by promotion behavioral health in children. JAMA. 2015;313:1509-10.
Fields M, Boat TF, IOM Report. Safe and Effective Medicines for Children. Washington (DC):National Academies Press (US);2012.
Fields M, Boat TF, IOM Report. Accelerating Rare Diseases Research and Orphan Products Development. Washington (DC):National Academies Press (US);2010.
Boat TF. Insights From Trends in Biomedical Research Funding. JAMA. 2010;303(2):170-71.
Boat TF, Chao SM, O’Neill PH. From Waste to Value in Health Care. JAMA. 2008;299(5):568-571.
O’Connell ME, Boat TF, Warner KE, National Research Council and Institute of Medicine Report. Preventing Mental, Emotional, and Behavioral Disorders Among Young People: Progress and Possibilities. Washington (DC):National Academies Press (US);2009.
Boat TF. The Future of Pediatric Research. J Pediatr. 2007 Nov;151(5 Suppl):S21-7.
Britto MT, Kotagal UR, Boat TF. Listening to families: first steps toward improved hospital care. Arch Pediatr Adolesc Med. 2005 Feb;159(2):187-8.
Abrams MT, Patchan KM, Boat TF. Research Training in Psychiatry Residency: Strategies for Reform. Washington (DC):National Academies Press (US);2003.
Ronald E. Bokulic, DO 513-636-6771
Associate Professor, UC Department of Pediatrics
Asthma; interstitial lung disease; exercise
DO: Philadelphia College of Osteopathic Medicine, 1983.
Residency: Pediatrics, Children's Medical Center, Dallas, TX.
Fellowship: Pediatric Pulmonary Medicine, Tulane University Medical School, New Orleans, LA.
Certification: Pediatrics, 1989; Pediatric Pulmonology, 1994.
Burrow TA, Cohen MB, Bokulic R, Deutsch G, Choudhary A, Falcone RA Jr, Grabowski GA. Gaucher disease: progressive mesenteric and mediastinal lymphadenopathy despite enzyme therapy. J Pediatr. 2007 Feb;150(2):202-6.
Amin RS, Carroll JL, Jeffries JL, Grone C, Bean JA, Chini B, Bokulic R, Daniels SR. Twenty-four-hour ambulatory blood pressure in children with sleep-disordered breathing. Am J Respir Crit Care Med. 2004 Apr 15;169(8):950-6.
Evans DA, Bokulic RE. Radiological case of the month. Posttraumatic pseudocysts. Arch Pediatr Adolesc Med. 1997 Aug;151(8):47-9.
Hardie W, Bokulic R, Garcia VF, Reising SF, Christie CD. Pneumococcal pleural empyemas in children. Clin Infect Dis. 1996 Jun;22(6):1057-63.
Bokulic RE, Hilman BC. Interstitial lung disease in children. Pediatr Clin North Am. 1994 Jun;41(3):543-67.
Lisa A. Burns, MD Pulmonologist, Pediatric and Adult Centers, Division of Pulmonary Medicine 513-636-6771 firstname.lastname@example.org
Pulmonologist, Pediatric and Adult Centers, Division of Pulmonary Medicine
Cystic fibrosis; chronic respiratory failure
MD: Loyola University, Chicago, Stritch School of Medicine, 2002.
Residency: Internal Medicine/Pediatrics, St. Louis University, St. Louis, MO.
Certification: ABP, 2006, ABIM, 2007.
Kelly C. Byars, PsyD Pediatric Psychologist, Clinical, Behavioral Medicine & Clinical Psychology 513-636-4336 email@example.com
Pediatric Psychologist, Clinical, Behavioral Medicine & Clinical Psychology
Pediatric behavioral sleep medicine
Kelly C. Byars, PsyD, is a professor of clinical pediatrics for Behavioral Medicine and Clinical Pediatrics at Cincinnati Children's Hospital Medical Center within the UC Department of Pediatrics. Dr. Byars is a pediatric behavioral psychologist who specializes in behavioral assessment and treatment of children with acute and chronic medical conditions. His primary areas of interest are pediatric sleep disorders, pediatric dysphagia and pediatric elimination disorders. Dr. Byars directs the Behavioral Sleep Medicine Program at Cincinnati Children's. He is also involved in the clinical training of postdoctoral fellows and residents.
Dr. Byars' research interests are closely tied to his clinical practice. Dr. Byars has published research focusing on a number pediatric illness groups including feeding disorders, cardiac illness, cancer, sickle cell disease, cystic fibrosis and insulin-dependent diabetes. Dr. Byars collaborates with other investigators at Cincinnati Children's. His current research efforts are focused on improving behavioral assessment and treatment strategies for children with sleep and feeding disorders.
Dr. Byars received his PsyD from the Georgia School of Professional Psychology in Atlanta, GA. He completed an internship in pediatric psychology at the Kennedy Krieger Institute and the Johns Hopkins University School of Medicine. He completed a postdoctoral fellowship in pediatric psychology at Cincinnati Children's. Dr. Byars joined the faculty of Cincinnati Children's and the University of Cincinnati College of Medicine in July 2000.
PsyD: Georgia School of Professional Psychology, Atlanta, GA, 1998.
Residency: Clinical Psychology / Developmental and Behavioral Pediatrics, The Kennedy Krieger Institute and Johns Hopkins University School of Medicine, Baltimore, MD.
Fellowship: Cincinnati Children' s Hospital Medical Center, Cincinnati, Ohio, 2000.
Certification: Licensure in Psychology, State of Ohio, 2000; National Register of Health Service Providers in Psychology, 2001; Certification in Behavioral Sleep Medicine, American Academy of Sleep Medicine, June 2005.
Becker SP, Langberg JM, Byars KC. Advancing a biopsychosocial and contextual model of sleep in adolescence: a review and introduction to the special issue. Journal of Youth and Adolescence. 2015;44:239-270.
Becker SP, Ramsey RR, Byars KC. Convergent Validity of the Child Behavior Checklist sleep items with validated sleep measures and sleep disorder diagnoses in children and adolescents referred to a sleep disorders center. Sleep Medicine. 2015 Jan;16(1):79-86.
Byars K, Simon S. Practice patterns and insomnia treatment outcomes from an evidence-based pediatric behavioral sleep medicine clinic. Clinical Practice in Pediatric Psychology. 2014;2(3):337-349.
Malow B, Byars KC, Johnson Weiss S, Bernal P, Goldman SE, Panzer R, Coury D, Glaze D. A Practice Pathway for the Identification, Evaluation and Management of Insomnia in Children and Adolescents with Autism Spectrum Disorders. Pediatrics. 2012;130:S106.
Beebe DW, Byars KC. Adolescents with obstructive sleep apnea adhere poorly to positive airway pressure (PAP), but PAP users show improved attention and school performance. PLoS One. 2011 Mar 17;6(3):e16924.
Byars K, Apiwattanasawee P, Leejakpai A, Tangchityongsiva S, Simakajornboom N. Behavioral sleep disturbances in children clinically referred for evaluation of obstructive sleep apnea. Sleep Med. 2011 Feb;12(2):163-9.
Byars AW, Byars KC, Johnson CS, DeGrauw TJ, Fastenau PS, Perkins S, Austin JK, Dunn DW. The relationship between sleep problems and neuropsychological functioning in children with first recognized seizures. Epilepsy Behav. 2008 Nov;13(4):607-13.
Meltzer L, Mindell J, Owens J, Byars KC. The Use of Sleep Medications in Hospitalized Pediatric Patients. Pediatrics. 2007;119(6):1047–55.
Byars, K. Scheduled awakenings: A behavioral protocol for treating sleepwalking and sleep terrors in children. In M. Perlis, M. Aloia, and B. Kuhn, (Eds.) Behavioral treatments for sleep disorders: A comprehensive primer of behavioral sleep medicine interventions. London: London: Elsevier Academic Press, 2010.
Byars KC, Amin R. Fatigue and Sleep Disorders. In G. Slapp (Ed.) Adolescent Medicine: The Requisites in Pediatrics. Philadelphia: Elsevier Press, 2008.
Barbara Chini, MD Director, Pulmonary Fellowship Program 513-636-6771 firstname.lastname@example.org
Director, Pulmonary Fellowship Program
Assistant Cystic Fibrosis Center Director, Division of Pulmonary Medicine
BS: University of Notre Dame Notre Dame, IN, 1986.MD: Vanderbilt University Medical School, Nashville, TN, 1990.
Internship: Pediatrics, University of Rochester Medical Center Pediatrics, Rochester, NY, 1991.
Residency: Pediatrics, University of Rochester Medical Center, Rochester, NY, 1993.
Fellowships: University of Rochester Medical Center, Rochester, NY, 1994; Children’s Hospital Medical Center, Cincinnati, OH, 1997.
Fricke BL, Donnelly LF, Shott SR, Kalra M, Poe SA, Chini BA, Amin RS. Comparison of lingual tonsil size as depicted on MR imaging between children with obstructive sleep apnea despite previous tonsillectomy and adenoidectomy and normal controls. Pediatr Radiol. 2006 Jun;36(6):518-23.
Shott SR, Amin R, Chini B, Heubi C, Hotze S, Akers R. Obstructive sleep apnea – Should all children with Down syndrome be tested? Arch Otolaryngol Head Neck Surg. 2006 Apr;132(4):432-436.
Mannaa M, Chini B. A case in point. A boy with shortness of breath, cough, and myalgias. J Respiratory Diseases. 2006;27(8):356-8.
Beebe DW, Wells CT, Jeffries J, Chini B, Kalra M, Amin RS. Neuropsychological Effects of Pediatric Obstructive Sleep Apnea. JINS. 2004 Nov;10(7):962-975.
Abbott MB, Donnelly LF, Dardzinski BJ, Poe SA, Chini BA, Amin RS. Obstructive Sleep Apnea: MR Imaging Volume Segmentation Analysis. Radiology. 2004 Sep;232(3):889-895.
Amin RS, Carroll J, Bean J, Jeffries J, Chini B, Bokulic R, Daniels S. Twenty Four Hour Ambulatory Blood Pressure in Children with Obstructive Sleep Apnea. Am J Respir Crit Care Med. 2004 Apr;169(8):950-56.
Donnelly LF, Shott SR, Connor RL, Chini BA, Amin RS. Causes of Persistent Obstructive Sleep Apnea Despite Previous Tonsillectomy and Adenoidectomy in Children with Down Syndrome as Depicted on Static and Dynamic Cine MRI. AJR. 2004 Jul;183(1):175-181.
John P. Clancy, MD Gunnar Esiason/Cincinnati Bell Chair 513-636-6771 email@example.com
Gunnar Esiason/Cincinnati Bell Chair
Research Director, Division of Pulmonary Medicine
Cystic fibrosis; airway cellular biology; CFTR regulation
John P. Clancy, MD, has served in several leadership roles at Univeristy of Alabama, Cincinnati Children's and within the international cystic fibrosis (CF) community. Some of his leadership roles include membership on the CFF Clinical Research Committee (2003 – present), the CFF-TDN Steering Committee (2002 – 2007), the CFF-TDN Translational Research Center Committee (2008 – present), DSMB membership for the Rare Lung Disease Consortium within the NIH Rare Disease Research Network (2005-2009, Chairman from 2010 – present); organizing committee membership for the North American CF Conference (2003- present) and the European CF Society (2010), Co-chair of the CFFT Biomarkers Consortium (2010- present), member of the Promotion and Tenure Committee for the UAB Department of Pediatrics (2003 - 2010) and the UAB SOM (2007 – 2010, including committee Chair).
Dr. Clancy has been the primary or co-mentor of more than 20 fellows, graduate students and junior faculty. He has been the initial recipient of two endowed chairs, including the Raymond K. Lyrene Chair in Pediatric Pulmonary Medicine at the University of Alabama (2005), and the Tom Boat Chair in Cystic Fibrosis Clinical and Translational Research at Cincinnati Children's (2011).
MD: University of Iowa College of Medicine, Iowa City, IA.
Residency: University of Virginia, Charlottesville, VA.
Fellowship: University of Alabama at Birmingham, Birmingham, AL.
Hug MJ, Derichs N, Bronsveld I, Clancy JP. Measurement of ion transport function in rectal biopsies. Methods Mol Biol. 2011;741:87-107.
Rowe SM, Clancy JP, Wilschanski M. Nasal potential difference measurements to assess CFTR ion channel activity. Methods Mol Biol. 2011;741:69-86.
Accurso FJ, Rowe SM, Clancy JP, Boyle MP, Dunitz JM, Durie PR, Sagel SD, Hornick DB, Konstan MW, Donaldson SH, Moss RB, Pilewski JM, Rubenstein RC, Uluer AZ, Aitken ML, Freedman SD, Rose LM, Mayer-Hamblett N, Dong Q, Zha J, Stone AJ, Olson ER, Ordoñez CL, Campbell PW, Ashlock MA, Ramsey BW. Effect of VX-770 in persons with cystic fibrosis and the G551D-CFTR mutation. N Engl J Med. 2010 Nov 18;363(21):1991-2003.
Clancy JP. Diagnosing cystic fibrosis in patients with non-diagnostic results: the case for intestinal current measurements. Thorax. 2010 Jul;65(7):575-6.
Rowe SM, Pyle LC, Jurkevante A, Varga K, Collawn J, Sloane PA, Woodworth B, Mazur M, Fulton J, Fan L, Li Y, Fortenberry J, Sorscher EJ, Clancy JP. DeltaF508 CFTR processing correction and activity in polarized airway and non-airway cell monolayers. Pulm Pharmacol Ther. 2010 Aug;23(4):268-78.
Com G, Clancy JP. Adenosine receptors, cystic fibrosis, and airway hydration. Handb Exp Pharmacol. 2009;(193):363-81.
Rowe SM, Clancy JP. Pharmaceuticals targeting nonsense mutations in genetic diseases: progress in development. BioDrugs. 2009;23(3):165-74.
Rowe SM, Accurso F, Clancy JP. Detection of cystic fibrosis transmembrane conductance regulator activity in early-phase clinical trials. Proc Am Thorac Soc. 2007 Aug 1;4(4):387-98. Rowe SM, Varga K, Rab A, Bebok Z, Byram K, Li Y, Sorscher EJ, Clancy JP. Restoration of W1282X CFTR activity by enhanced expression. Am J Respir Cell Mol Biol. 2007 Sep;37(3):347-56.
Joseph Crisalli, MD 513-636-6771 firstname.lastname@example.org
MD: Emory University School of Medicine, Atlanta, GA, 2002.
Residency: Cincinnati Children's Hospital Medical Center, Cincinnati, OH.
Deborah A. Elder, MD Pediatric Endocrinologist, Division of Endocrinology 513-636-4744 email@example.com
Pediatric Endocrinologist, Division of Endocrinology
Type 1 diabetes; type 2 diabetes; cystic-fibrosis-related diabetes; assessment of beta-cell function in the evaluation of total pancreatectomy and islet autotransplantation (TPAIT) in children with chronic pancreatitis; growth disorders; precocious puberty; pancreatic center member; cystic fibrosis and endocrine combined clinic; lung transplantation center member.
BS: Michigan State University, 1991.
MD: University of Kentucky College of Medicine, Lexington, KY, 1995.
Residency: Indiana University Riley Hospital For Children, Indianapolis, IN, 1998.
Fellowship: University of North Carolina at Chapel Hill, Chapel Hill, NC, 2001.
Certification: Pediatric endocrinology.
Auble B, Elder D, Gross A, Hillman JB. Differences in the Management of Adolescents with Polycystic Ovary Syndrome across Pediatric Specialties. J Pediatr Adolesc Gynecol. 2013 May 28.
Elder DA, Herbers P, Weis T, Standiford D, Woo JG, D’Alessio DA. Beta-cell function in adolescent and adults with newly diagnosed type 2 diabetes mellitus. J. Pediatr. June 2012;160(6):904-10.
Elder DA, Woo JG, D’Alessio DA. Impaired beta-cell sensitivity to glucose and maximal insulin secretory capacity in adolescents with type 2 diabetes. Ped Diabetes. 2010; 11(5):314-21.
Elder DA, D’Alessio DA, Eyal O, Mueller R, Smith FO, Kansra AR, Rose SR. Abnormalities in Glucose Tolerance Are Common in Children with Fanconi Anemia and Associated with Impaired Insulin Secretion. Pediatric Blood & Cancer. 2008; 51(2):256-60.
Elder DA, Wooldridge JL, Dolan LM, D’Alessio DA. Glucose Tolerance in Children and Adolescents with Cystic Fibrosis and No Prior History of Diabetes. J Pediatr. 2007;151(6):653-8.
Elder DA, Prigeon RL, Wadwa RP, Dolan LM, D’Alessio DA. Beta-cell Function, Insulin Sensitivity and Glucose Tolerance in Obese Diabetic and Nondiabetic Adolescents and Young Adults. J Clin Endocrinol Metab. 2006;91(1):185-91.
Eyal O, Naffaa LN, Elder DA. A Case of Macroprolactinoma and Elevated Insulin-Like Growth Factor-I in a Young Boy. Acta Paediatr. 2005;94(12):1852-6.
Elder DA, Roper MG, Henderson RC, Davenport ML. Kyphosis in a Turner Syndrome Population. Pediatrics. 2002;109(6):e93.
Elder DA, Kaiser-Rogers K, Aylsworth AS, Calikoglu AS. Type 1 diabetes mellitus in a patient with chromosome 22q11.2 deletion syndrome. American Journal of Medical Genetics. 2001; 101(1):17-9.
Elder DA, Karayal AF, D’Ercole AJ, Calikoglu AS. Effects of hypothyroidism on insulin-like growth factor-I expression during brain development in mice. Neuroscience Letters. 2000; 293(2):99-102.
Stephanie Spear Filigno, PhD Pediatric Psychologist, Clinical, Behavioral Medicine & Clinical Psychology 513-636-4336 firstname.lastname@example.org
Behavior management in toddlers and preschoolers; adherence to treatment in chronic illness (CF and obesity); coping and adjustment; child anxiety; toileting
Stephanie Spear Filigno, PhD, joined Behavioral Medicine and Clinical Psychology as an assistant professor within the UC Department of Pediatrics after completing her research fellowship at Cincinnati Children’s under the mentorship of Drs. Scott Powers and Lori Stark.
During her fellowship she developed and delivered family-based behavior and nutrition treatments for obese preschoolers and young children with cystic fibrosis. She continues to collaborate on these projects, and independently develop quality improvement projects in cystic fibrosis with an early intervention behavior and nutrition focus.
Stephanie also works with the Cystic Fibrosis Center to help families cope with the demands of the cystic fibrosis treatment regimen, reach nutrition recommendations, and improve adherence to treatment.
PhD: University of Nevada, Reno, NV, 2007.
Internship: Boystown, Nebraska Internship Consortium of Professional Psychology, Omaha, NE, 2006-2007.
Fellowship: Pediatric Psychology, Cincinnati Children’s Hospital Medical Center, Cincinnati, OH, 2007-2009.
Stark LJ, Spear S, Boles R, Kuhl E, Ratcliff M, Scharf C, Bolling C, Rausch J. A pilot randomized controlled trial of a clinic and home-based behavioral intervention to decrease obesity in preschoolers. Obesity (Silver Spring). 2011 Jan;19(1):134-41.
Borowitz B, Robinson K, Rosenfeld M, Davis SD, Sabadosa KA, Spear SL, Michel SH, Parad RB, White TB, Farrell PM, Marshall BC, Accurso FJ. Cystic Fibrosis Foundation Evidence-Based Guidelines for Management of Infants with Cystic Fibrosis. Journal of Pediatrics. 2009;155(6):S73-S93.
Daniel H. Grossoehme Chaplain, Division of Pulmonary Medicine 513-636-0848 email@example.com
Chaplain, Division of Pulmonary Medicine
Adherence; spirituality and religion; chronic illness coping and HRQoL.
Visit the Grossoehme Lab.
Doctor of Ministry: (Pastoral Counseling), Louisville Presbyterian Theological Seminary, 2006.
MDiv: Protestant Episcopal Theological Seminary in Virginia, Alexandria, VA, 1992.
BS: Astrophysics, Indiana University, 1985.
Grossoehme DH, Opipari-Arrigan L, VanDyke R, Thurmond S, Seid M. Relationship of adherence determinants and parental spirituality in cystic fibrosis. Pediatr Pulmonol. 2012 Jun;47(6):558-66.
Grossoehme DH, Jacobson CJ, Cotton S, Ragsdale J, VanDyke R, Seid M. Written prayers and religious coping in a paediatric hospital setting. Mental Health, Religion & Culture. 2011 14(5): 423-432.
Grossoehme DH, Ragsdale JR, Snow A, Seid M. We were chosen as a family: Parents’ evolving use of religion when their child has cystic fibrosis. J Relig Health. 2012 Dec;51(4):1347-58.
Cotton S, Grossoehme DH, McGrady M. Religious coping and use of prayer in sickle cell disease. Pediatric Blood Cancer. 2012 Feb;58(2):244-9.
Grossoehme DH, VanDyke R, Jacobson CJ, Cotton S, Ragsdale J, Seid M. Written prayers in a pediatric hospital: linguistic analysis. Psychology of Religion & Spirituality. 2010 2(4): 227-233.
Grossoehme DH, Ragsdale JR, Wooldridge JL, Cotton S, Grimes L, Seid M. Parents’ use of religious coping in the first year after their child’s chronic illness diagnosis. Journal of Health Care Chaplaincy. 2010 16(3): 109-122.
Grossoehme DH, Ragsdale J, Wooldridge JL, Cotton S, Seid M. We can handle this: Parents’ use of religion in the first year following their child’s diagnosis with cystic fibrosis. Journal of Health Care Chaplaincy. 2010 16(3): 95-108.
Grossoehme DH, VanDyke R, Seid M. Spirituality’s role in chronic disease self-management: Sanctification of the body in families dealing with cystic fibrosis. Journal of Health Care Chaplaincy. 2009 15, 1-10.
Cotton S, Grossoehme D, Rosenthal SL, McGrady ME, Roberts YH, Hines J, Yi MS, Tsevat J. Religious/spiritual coping in adolescents with sickle cell disease: A pilot study. Journal of Pediatric Hematology/Oncology. 2009 31(5), 313-318.
Grossoehme DH, Ragsdale J, Dixon C, Berz K, Zimmer M. The changing face of medical education: the role of religion, integrative medicine and osteopathy. The Open Medical Education Journal. 2009 2, 1-8.
Theresa W. Guilbert, MD, MS Associate Director, Asthma Center 513-636-6771 firstname.lastname@example.org
Associate Director, Asthma Center
Preschool wheezing; difficult-to-control asthma
Theresa Guilbert, MD, MS, is board certified in pediatrics and pediatric pulmonary and is a professor in the Division of Pulmonary Medicine at Cincinnati Children's within the UC Department of Pediatrics. She is the associate director of the Asthma Center and has 14 years of experience in providing clinical care to children and adolescents with asthma and conducting clinical and epidemiologic research. She has been selected as one of the Best Doctors in America for several years. Dr. Guilbert has been elected to serve on the Pulmonology Subboard of the American Board of Pediatrics, the American Thoracic Society (ATS) Pediatric Planning and the Pediatric Program Committees. In addition, she has trained and mentored several academic pediatric pulmonologists.
MD: University of Minnesota, Minneapolis, MN, 1992.
Residency: Pediatrics, University of Minnesota, Minneapolis, MN.
Fellowship: Pediatric Pulmonology, University of Colorado, Denver, CO.
MS: Epidemiology, University of Arizona, Tucson, AZ, 2007.
Tomasallo C, Hanrahan L, Tandias A, Cowan K, Guilbert TW. Estimating Wisconsin Asthma Prevalence Using Clinical Electronic Health Records and Public Health Data. Am J Public Health. 2014 Jan;104(1):e65-73.
Papadopoulos NG, Arakawa H, Carlsen KH, Custovic A, Gern J, Lemanske R, Le Souef P, Mäkelä M, Roberts G, Wong G, Zar H, Akdis CA, Bacharier LB, Baraldi E, van Bever HP, de Blic J, Boner A, Burks W, Casale TB, Castro-Rodriguez JA, Chen YZ, El-Gamal YM, Everard ML, Frischer T, Geller M, Gereda J, Goh DY, Guilbert TW, Hedlin G, Heymann PW, Hong SJ, Hossny EM, Huang JL, Jackson DJ, de Jongste JC, Lalayci O, Aït-Khaled N, Kling S, Kuna P, Lau S, Ledford DK, Lee SI, Liu AH, Lockey RF, Lødrup-Carlsen K, Lötvall J, Morikawa A, Nieto A, Paramesh H, Pawankar R, Pohunek P, Pongracic J, Price D, Robertson C, Rosario N, Rossenwasser LJ, Sly PD, Stein R, Stick S, Szefler, S, Taussig LM, Valovirta E, Vichyanond P, Wallace D, Weinberg E, Wennergren G, Wildhaber J, Zeiger RS. International consensus on (ICON) pediatric asthma. Allergy. 2012 Aug;67(8):976-97.
Zeiger RS, Mauger D, Bacharier LB, Guilbert TW, Martinez FD, Lemanske RF Jr, Strunk RC, Covar R, Szefler SJ, Boehmer S, Jackson DJ, Sorkness CA, Gern JE, Kelly HW, Friedman NJ, Mellon MH, Schatz M, Morgan WJ, Chinchilli VM, Raissy HH, Bade E, Malka-Rais J, Beigelman A, Taussig LM; CARE Network of the National Heart, Lung, and Blood Institute. Daily or intermittent budesonide in preschool children with recurrent wheezing. N Engl J Med. 2011 Nov 24;365(21):1990-2001.
Guilbert TW, Singh AM, Danov Z, Evans MD, Jackson DJ, Burton R, Roberg KA, Anderson EL, Pappas TE, Gangnon R, Gern JE, Lemanske RF Jr. Decreased lung function after preschool wheezing rhinovirus illnesses in children at high risk to develop asthma. J Allergy Clin Immunol. 2011 Sep;128(3):532-8.
Guilbert TW, Mauger DT, Allen DB, Zeiger RS, Lemanske RF, Jr., Szefler SJ, Strunk RC, Bacharier LB; Covar R, Sorkness CA, Taussig LM, Martinez FD, Childhood Asthma Research and Education Network of the National Heart, Lung, and Blood Institute. Growth of preschool children at high risk for asthma two years after discontinuation of fluticasone. J Allergy Clin Immunol. 2011 Nov;128(5):956-63.
Lemanske RF Jr, Mauger DT, Sorkness CA, Jackson DJ, Boehmer SJ, Martinez FD, Strunk RC, Szefler SJ, Zeiger RS, Bacharier LB, Covar RA, Guilbert TW, Larsen G, Morgan WJ, Moss MH, Spahn JD, Taussig LM; the Childhood Asthma Research and Education (CARE) Network of the National Heart, Lung, and Blood Institute. Step-up therapy for children with uncontrolled asthma receiving inhaled corticosteroids. N Engl J Med. 2010 Mar 18;362(11):975-85.
Guilbert TW, Stern DA, Morgan WJ, Martinez FD, Wright, AL. Effect Of Breastfeeding On Lung Function In Childhood And Modulation By Maternal Asthma Atopy. Amer J Respri Crit Care Med. 2007 Nov 1;176(9):843-8.
Guilbert TW, Morgan WJ, Zeiger RS, Mauger DT, Boehmer SJ, Szefler SJ, Bacharier LB, Lemanske RF Jr, Strunk RC, Allen DB, Bloomberg GR, Heldt G, Krawiec M, Larsen G, Liu AH, Chinchilli VM, Sorkness CA, Taussig LM, Martinez FD. Long-term inhaled corticosteroids in preschool children at high risk for asthma. N Engl J Med. 2006 May 11; 354(19):1985-97.
Morgan WJ, Stern DA, Sherrill D, Guerra S, Holberg CJ, Guilbert T, Taussig LM, Wright AL, Martinez FD. Outcome of asthma and wheezing in the first six years of life: follow-up through adolescence. Am J Respir Crit Care Med. 2005 Nov 15;172(10):1253-58.
Guilbert TW, Morgan WJ, Zeiger RS, Bacharier LB, Boehmer SJ, Krawiec M, Larsen G, Lemanske, Jr. RF, Liu A, Mauger DT, Sorkness C, Szefler SJ, Strunk RC, Taussig LM, Martinez FD. Atopic Characteristics of Children with Recurrent Wheezing at High-risk for the Development of Childhood Asthma. J Allergy Clin Immunol. 2004 Dec;114(6):1282-7.
Neepa S. Gurbani, DO 513-636-6771 email@example.com
DO: Western University of Health Sciences, Pomona, CA, 2006.
Residency: University of Nevada School of Medicine, Las vegas, NV, 2009.
Fellowship: Pediatric Pulmonology, Cincinnati Children’s Hospital, 2012; Sleep Medicine, Cincinnati Children’s Hospital, 2015.
William D. Hardie, MD 513-636-6771 firstname.lastname@example.org
Pulmonary function tests; pneumonia; empyema
MD: Vanderbilt University, Nashville, TN, 1990.
Residency: Children's Hospital Medical Center, Cincinnati, OH.
Fellowship: Children's Hospital Medical Center, Cincinnati, OH.
Certification: Pediatrics, 1993; Pulmonary Medicine, 1999.
Le Cras TD, Korfhagen TR, Davidson C, Schmidt S, Fenchel M, Ikegami M, Whitsett JA, Hardie WD. Inhibition of PI3K by PX-866 prevents transforming growth factor-alpha-induced pulmonary fibrosis. Am J Pathol. 2010 Feb;176(2):679-86
Deshmukh HS, McLachlan A, Atkinson JJ, Hardie WD, Korfhagen TR, Dietsch M, Liu Y, Di PY, Wesselkamper SC, Borchers MT, Leikauf GD. Matrix metalloproteinase-14 mediates a phenotypic shift in the airways to increase mucin production. Am J Respir Crit Care Med. 2009 Nov 1;180(9):834-45.
Hardie WD, Glasser SW, Hagood JS. Emerging concepts in the pathogenesis of lung fibrosis. Am J Pathol. 2009 Jul;175(1):3-16.
Korfhagen TR, Le Cras TD, Davidson CR, Schmidt SM, Ikegami M, Whitsett JA, Hardie WD. Rapamycin prevents transforming growth factor-alpha-induced pulmonary fibrosis. Am J Respir Cell Mol Biol. 2009 Nov;41(5):562-72.
Kramer EL, Mushaben EM, Pastura PA, Acciani TH, Deutsch GH, Khurana Hershey GK, Korfhagen TR, Hardie WD, Whitsett JA, Le Cras TD. Early growth response-1 suppresses epidermal growth factor receptor-mediated airway hyperresponsiveness and lung remodeling in mice. Am J Respir Cell Mol Biol. 2009 Oct;41(4):415-25.
Hardie WD. 50 Years Ago in The Journal of Pediatrics Pediatric Empyema: A Second Look at its Incidence and Importance. Kiesewetter, WB, Rusnock JR, Girdany BR. J Pediatr 1959;54:81-6. J Pediatr. 2009 Jan 1;154(1):131.
Loeb JS, Blower WC, Feldstein JF, Koch BA, Munlin AL, Hardie WD. Acceptability and repeatability of spirometry in children using updated ATS/ERS criteria. Pediatr Pulmonol. 2008 Oct;43(10):1020-4.
Hardie WD, Davidson C, Ikegami M, Leikauf GD, Le Cras TD, Prestridge A, Whitsett JA, Korfhagen TR. EGF receptor tyrosine kinase inhibitors diminish transforming growth factor-alpha-induced pulmonary fibrosis. Am J Physiol Lung Cell Mol Physiol. 2008 Jun;294(6):L1217-25.
Deshmukh HS, Shaver C, Case LM, Dietsch M, Wesselkamper SC, Hardie WD, Korfhagen TR, Corradi M, Nadel JA, Borchers MT, Leikauf GD. Acrolein-activated matrix metalloproteinase 9 contributes to persistent mucin production. Am J Respir Cell Mol Biol. 2008 Apr;38(4):446-54.
McPhail GL, Hardie WD. Cavitary lung lesions in a 2-year-old child. Respiration. 2008;76(1):117-8.
Stacey L. Ishman, MD, MPH Surgical Director, Upper Airway Center 513-636-4881 Sleep@cchmc.org
Surgical Director, Upper Airway Center
Associate Professor, UC Department of Otolaryngology, Head & Neck Surge
BS: Biology/Vertebrate Physiology, The Pennsylvania State University, State College, PA, 1992.
BA: Political Science, The Pennsylvania State University, State College, PA, 1992.
MD: Medicine, Rush Medical College, Chicago, IL, 2000.
Internship: General Surgery, Medical College of Wisconsin, Milwaukee, WI, 2001.
Residency: Otolaryngology, Medical College of Wisconsin, Milwaukee, WI, 2005.
Fellowship: Pediatric Otolaryngology, Johns Hopkins School of Medicine, Baltimore, MD, 2006.
Advanced Training: Sleep Medicine, Johns Hopkins School of Medicine, Baltimore, MD, 2007.
MPH: Epidemiology, Johns Hopkins Bloomberg School of Public Health, Baltimore, MD, 2010.
Carolyn M. Kercsmar, MD Co-Director, Division of Pulmonary Medicine 513-636-6771 email@example.com
Co-Director, Division of Pulmonary Medicine
Director, Asthma Center
BS: Biology, Baldwin-Wallace College, Cleveland, OH, 1972.
MD: Case Western Reserve University, Cleveland, OH, 1978.
MS: Anatomy, Case Western Reserve University, Cleveland, OH, 1978.
Kercsmar C. Exhaled nitric oxide in the diagnosis and management of childhood asthma. Ther Adv Respir Dis. 2010 Apr;4(2):71-82.
Kattan M, Kumar R, Bloomberg GR, Mitchell HE, Calatroni A, Gergen PJ, Kercsmar CM, Visness CM, Matsui EJ, Steinbach SF, Szefler SJ, Sorkness CA, Morgan WJ, Teach SJ, Gan VJ. Asthma control, adiposity, and adipokines among inner-city adolescents. J Allergy Clin Immunol. 2010 125:584-92.
Rohan J, Drotar D, McNally K, Schluchter M, Riekert K, Vavrek P, Schmidt A, Redline S, Kercsmar C. Adherence to pediatric asthma treatment in economically disadvantaged African-American children and adolescents: an application of growth curve analysis. J Pediatr Psychol. 2010 May;35(4):394-404.
Ross KR, Hart MA, Storfer-Isser A, Kibler AM, Johnson NL, Rosen CL, Kercsmar CM, Redline S. Obesity and obesity related co-morbidities in a referral population of children with asthma. Pediatr Pulmonol. 2009 Sep;44(9):877-84.
McNally KA, Rohan J, Schluchter M, Riekert KA, Vavrek P, Schmidt A, Redline S, Kercsmar C, Drotar D. Adherence to combined montelukast and fluticasone treatment in economically disadvantaged African American youth with asthma. J Asthma. 2009 Nov;46(9):921-7.
Kercsmar CM, McDowell KM. Love it or Lev it: Levalbuterol for severe acute asthma; for now, leave it. J Pediatr. 2009 155:163-64.
Short EJ, Kirchner HL, Asaad GR, Fulton S, Lewis B, Eisengart S, Baley J, Kercsmar C, Min MO, Singer LT. Long-term Sequelae of Postnatal Surfactant and Corticosteroid Therapies. BPD J Perinatol. 2008 Jul; 28(7):498-504.
Szefler SL, Mirchell H, Sorkness CA, Gergen PJ, O'Connor GT, Morgan WJ, Kattan M, Pongracic JA, Teach SJ, , Bloomberg GR, Eggleston PA, Gruchalla RS, Kercsmar CM, Liu, AH, Wildfire JJ, Busse WW. Management of asthma based on exhaled nitric oxide in addition to guideline-based treatment for inner-city adolescents and young adults: a randomised controlled trial. Lancet. 2008 372:1065-72.
Kercsmar CM. Meeting the challenges of asthma: conference summary. Respir Care. 2008 Jun;53(6):787-95.
Sobande PO, Kercsmar CM. Inhaled corticosteroids in asthma management. Respir Care. 2008 May;53(5):625-33; discussion 633-4. Review.
Satish K. Madala, PhD 513-636-9852 firstname.lastname@example.org
Dr. Madala’s research interests are to identify the cellular and molecular mechanisms involved the initiation, maintenance, and progression of pulmonary fibrosis. His lab’s research tools include using molecular, biochemical and immunology methods to identify novel therapeutic targets in chronic lung diseases such as idiopathic pulmonary fibrosis (IPF) and systemic sclerosis (SSc), and cystic fibrosis (CF). The lab’s early studies using several mouse models of fibrosis have revealed that multiple growth factors contribute to the deposition of collagen and other extracellular matrix (ECM) proteins in the lung. The lab’s recent studies have helped to define unique functions of fibrocytes and their heterogeneous interactions with other lung stromal cells in causing the expansion of adventitial and pleural fibrotic lesions in the lung.
Postdoctoral training: Wynn Lab, Immunopathogenesis Section, LPD, NIAD, NIH, Bethesda, MD.
PhD: National Institute of Nutrition, Osmania University, Hyderabad, India.
Madala SK*, Edukulla R, Davis KR, Schmidt SM, Davidson CR, Ikegami M. Hardie WD. Bone marrow-derived stromal cells are invasive and hyperproliferative and alter TGFα-induced fibrosis. Am J Respir Cell Mol Bio. 2014 Apr;50(4):777-86. * Corresponding author
Madala SK*, Edukulla R, Davis KR, Schmidt SM, Davidson CR, Kitzmiller JA, Hardie WD, Korfhagen TA. Resistin-like molecule alpha1 (Fizz1) recruits lung dendritic cells without causing pulmonary fibrosis. Respir Res. 2012 Jun 22;13:51. *Corresponding author
Madala SK, Schmidt SM, Davidson CR, Ikegami M, Susan W, Hardie WD. MEK-ERK pathway modulation ameliorates pulmonary fibrosis associated with epidermal growth factor receptor activation. Am J Respir Cell Mol Bio. 2012 Mar 46(3):380-8.
Wynn TA, Barron L, Thompson RW, Madala SK, Wilson MS, Cheever AW, Ramalingam TR. Quantitative Assessment of Macrophage Functions in Repair and Fibrosis. Curr Protoc Immunol. 2011 Apr; Chapter 14:Unit14.22.
Madala SK, Dolan M, Sharma D, Ramalingam TR, Wilson MS, Mentink-Kane MM,Wynn TA. Mapping mouse IL-13 binding regions using structure modeling, molecular docking and high-density peptide microarray analysis. Proteins. 2011 Jan;79(1):282-93.
Wilson MS, Ramalingam TR, Rivollier A, Shenderov K, Mentink-Kane MM, Madala SK, Cheever AW, Artis D, Kelsall BL, Wynn TA. Colitis and intestinal inflammation in IL10-/- mice results from IL-13Rα2-mediated attenuation of IL-13 activity. Gastroenterology. 2011 Jan;140(1):254-64 .
Wilson MS, Madala SK, Ramalingam TR, Thompson RW Mentink-Kane MM, Cheever AW, Wynn TA. Bleomycin and IL-1β mediated pulmonary fibrosis is regulated by IL-10 and dependent on IL-17A. J Exp Med. 2010 Mar 15;207(3):535-52.
Madala SK, Pesce J, Ramalingam TR, Wilson MS, Thompson RW, Minnicozzi S, Mentink-Kane MM, Cheever AW,Wynn TA. Matrix metalloproteinase 12-deficiency augments extracellular matrix degrading metalloproteinases and attenuates IL-13-dependent fibrosis. J Immunol. 2010 Apr 1;184(7):3955-63.
Ramalingam TR, Pesce JT, Mentink-Kane MM, Madala SK, Cheever AW, Comeau MR, Ziegler SF, Wynn TA. Regulation of helminth-induced Th2 responses by thymic stromal lymphopoietin. J Immunol. 2009 May 15;182(10):6452-9.
Role of TGFα-induced fibrocytes in pulmonary fibrosis and pulmonary hypertension. Principal Investigator. American Heart Association NCRP Scientist Development Grant. Jan 2012-Dec 2015.
Role of IL-31 in immunopathology of Systemic sclerosis (SSc). Principal Investigator. Bristol-Myers Squibb preclinical contract. 2013-2016. R03 NIAMS.
Molecular Mechanisms of Pulmonary Fibrosis. Principal Investigator. Parker B. Francis Fellowship. 2013-Dec 2016.
Karen M. McDowell, MD Director, Infant Pulmonary Function Lab 513-636-6771 email@example.com
Director, Infant Pulmonary Function Lab
Asthma; flexible bronchoscopy; general pediatric pulmonology; quality improvement methodologies; infant pulmonary function test
BS: College of William and Mary, Williamsburg, VA, 1983.
MS: University of Connecticut, Storrs, CT, 1986.
MD: Temple University School of Medicine, Philadelphia, PA, 1990.
Residency: Rainbow Babies and Children's Hospital, Cleveland, OH.
Fellowship: Rainbow Babies and Children's Hospital, Cleveland, OH.
Certification: Pediatric Pulmonology, 1996.
McDowell KM, Craven DI. Pulmonary complications of Down syndrome during childhood. J Pediatr. 2011 Feb;158(2):319-25.
Kercsmar CM, McDowell KM. Love It or Lev It: The Role of Levalbuterol in Acute Severe Asthma—For now, Leave it. J Pediatr. 2009 155(2):162-164.
Richards MM, Banez, GA, McDowell KM. Pediatric Puzzler. Pediatric Perspectives. April 2006.
Ogunmola N, Wyllie R, McDowell K, Kay M, Mahajan L. Endoscopic closure of esophagobronchial fistula with fibrin glue. J Pediatr Gastroenterol Nutr. 2004 38(5): 539-541.
Gary Lewis McPhail, MD Cystic Fibrosis Center Director, Division of Pulmonary Medicine 513-636-6771 firstname.lastname@example.org
Cystic Fibrosis Center Director, Division of Pulmonary Medicine
Associate Director, Fellowship Training Program
Medical education; outcomes research; quality improvement; sleep medicine; thoracic insufficiency syndrome
MD: University of Texas Southwestern Medical Center, Dallas TX, 2001.
Residency: Children's Medical Center, University of Texas Southwestern, Dallas TX, 2004.
Fellowship: Cincinnati Children's Hospital Medical Center, Cincinnati, OH, 2007.
Certification: Pediatrics, 2004; Pediatric Pulmonary, 2008.
McPhail GL, Weiland J, Acton JD, Ednick M, Chima A, VanDyke R, Fenchel MC, Amin RS, Seid M. Improving evidence-based care in cystic fibrosis through quality improvement. Arch Pediatr Adolesc Med. 2010 Oct;164(10):957-60.
McPhail GL, Ednick MD, Fenchel MC, VanDyke R, Chima A, Amin RS, Seid M. Improving follow-up in hospitalised children. Qual Saf Health Care. 2010 Oct;19(5):e35
Ednick M, Cohen AP, McPhail GL, Beebe D, Simakajornboon N, Amin RS. A review of the effects of sleep during the first year of life on cognitive, psychomotor, and temperament development. Sleep. 2009 Nov 1;32(11):1449-58. Review.
McPhail GL, Acton JD, Fenchel MC, Amin RS, Seid M. Improvements in lung function outcomes in children with cystic fibrosis are associated with better nutrition, fewer chronic pseudomonas aeruginosa infections, and dornase alfa use. J Pediatr. 2008 Dec;153(6):752-7.
McPhail GL. Coagulation disorder as a presentation of cystic fibrosis. J Emerg Med. 2010 Apr;38(3):320-2.
Amin R, Somers VK, McConnell K, Willging P, Myer C, Sherman M, McPhail G, Morgenthal A, Fenchel M, Bean J, Kimball T, Daniels S. Activity-adjusted 24-hour ambulatory blood pressure and cardiac remodeling in children with sleep disordered breathing. Hypertension. 2008 Jan;51(1):84-91.
McPhail GL, Hardie WD. Cavitary lung lesions in a 2-year-old child. Respiration. 2008;76(1):117-8.
Anjaparavanda P. (AP) Naren, PhD Thomas Boat Chair in Cystic Fibrosis Research 513-803-4731 email@example.com
Thomas Boat Chair in Cystic Fibrosis Research
Co-Director, Cystic Fibrosis Research Center
Cystic fibrosis; secretory diarrhea.
Cystic fibrosis transmembrane conductance regulator (CFTR) is a cAMP-regulated chloride channel located primarily on the apical surface of epithelial cells that line various organs, including the airways and the gut. CFTR dysfunction is detrimental and may result in life-threatening medical disorders. Dr. Naren's laboratory studies two such disorders; (1) Cystic fibrosis, a lethal genetic disease that affects mostly the Caucasian population (>30,000 in USA), in which the CFTR chloride channel is HYPO-functional and (2) Secretory diarrhea, a disease affecting millions of children worldwide, in which HYPER-function of the CFTR chloride channel can occur due to infectious toxins, such as cholera toxin and E. coli enterotoxin. His lab is interested in identifying interactions between CFTR and its binding partners and defining how spatiotemporal regulation of CFTR-containing macromolecular complexes in the apical compartment of polarized epithelial cells lining the secretory epithelia regulates overall fluid secretion. Our studies will identify new drug targets for cystic fibrosis, secretory diarrhea, and other diseases resulting from CFTR dysfunction and provide insights into the etiology of diseases associated with CFTR-interacting molecules.
Ren A, Zhang W, Sunitha Y, Arora K, Sinha C, Moon CS, Naren AP. MAST205 Competes with CAL for Binding to CFTR to Regulate CFTR-mediated Fluid Transport. J Biol Chem. 2013 April:26;288(17):12325-34.
Yarlagadda S, Zhang W, Penmatsa H, Ren A, Arora K, Naren AP*, Khan FA, Donnellan C, Srinivasan S, Stokes D, Kappes JC. A Young Hispanic with c.1646G>A Mutation Exhibits Severe Cystic Fibrosis Lung Disease: Is Ivacaftor an Option for Therapy? Am J Respir Crit Care Med. 2012 Oct:1 186(7):694-6. (*Corresponding Author)
Zhang W, Penmatsa H, Ren A, Punchihewa C, Lemoff A, Yan B, Fujii N, Naren AP. Functional regulation of CFTR-containing macromolecular complexes: a small-molecule inhibitor approach. Biochem J. 2011 April:15;435(2):451–62
Penmatsa H, Zhang W, Yarlagadda S, Li C, Conoley VG, Yue J, Bahouth SW, Buddington RK, Zhang G, Nelson DJ, Sonecha MD, Manganiella V, Wine JJ, Naren AP. Compartmentalized cyclic adenosine 3’,5’-monophosphate at the plasma membrane clusters PDE3A and cystic Fibrosis transmembrane conductance regulator into microdomains. Mol Biol Cell. 2010 Mar:15;21:1097-110.
Li C, Krishnamurthy PC, Penmatsa H, Marrs KL, Wang XQ, Zaccolo M, Jalink K, Li M, Nelson DJ, Schuetz JD, Naren AP. Spatiotemporal Coupling of cAMP Transporter to CFTR Chloride Channel Function in the Gut Epithelia. Cell. 2007 Nov:30;131(5): 940-51.
Li C, Dandridge KS, Di A, Marrs KL, Harris EL, Roy K, Jackson JS, Makarova NV, Fujiwara Y, Farrar, PL, Nelson DJ, Tigyi GJ, Naren AP. Lysophosphatidic acid inhibits cholera toxin-induced secretory diarrhea through CFTR-dependent protein interactions. J Exp Med. 2005 Oct:3; 202(7):975-86.
Naren AP, Cobb B, Li C, Roy K, Nelson D, Heda GD, Liao J, Kirk KL, Sorscher EJ, Hanrahan J, Clancy JP. A macromolecular complex of beta 2 adrenergic receptor, CFTR, and ezrin/radixin/moesin-binding phosphoprotein 50 is regulated by PKA. Proc Natl Acad Sci USA. 2003 Jan:7;100(1):342-46.
Naren AP, Anke D, Cormet-Boyaka E, Boyaka PN, McGhee JR, Zhou W, Akagawa K, Fujiwara T, Thome U, Engelhardt JF, Nelson DJ, Kirk KL. Syntaxin 1A is expressed in airway epithelial cells, where it modulates CFTR Cl(-) currents. J Clin Invest. 2000 Feb;105(3):377-86.
Naren AP, Cormet-Boyaka E, Fu J, Villain M, Blalock E, Quick MW, Kirk KL. CFTR Chloride channel regulation by an interdomain interaction. Science. 1999 Oct:15;286(5439):544-8.
Naren AP, Nelson DJ, Xie W, Jovov B, Tousson A, Pevsner J, Bennett MK, Benos DJ, Quick MW, Kirk KL. Regulation of CFTR chloride channels by syntaxin and Munc18 isoforms. Nature. 1997 Nov:20;390(6657):302-5.
Inhibition of a cAMP transporter (MRP4) in the gut induces diarrhea. Principal Investigator. National Institutes of Health. June 2009-Apr 2018. DK080834.
LPA2-receptor containing complexes in regulating secretory diarrhea. Principal Investigator. July 2011-June 2020. RO1 (DK093045).
CF-Patient Specific Enteroids from Small Intestine and Colon. Principal Investigator. Cystic Fibrosis Foundation. July 2014-June 2016. NAREN14XXO.
Characterization of an inhibitory protein complex for cystic fibrosis therapy. Collaborator. Aug 2014-July 2019. RO1 (HL123535).
Personalizing Cystic Fibrosis Research Translation. Principal Investigator/Director-CF Human Model Systems Core. CFF-Research Development Project. July 2015-June 2019. CLANCY15R0.
Demonstrate that GC-C modulation of CFTR in the gut epithelia using enteroids from CF patients increases intestinal fluid secretion. Principal Investigator. Ironwood Grant. June 2015-May 2016. LIN-PH-44.
Hemant Sawnani, MD Member, Division of Pulmonary Medicine 513-636-6771 Sleep@cchmc.org
Member, Division of Pulmonary Medicine
Pediatric sleep disorders
MD: Seth GS Medical College/King Edward VIII Memorial Hospital, 1997.
Residency: Pediatrics, Brooklyn Hospital Medical Center, New York NY, 2000.
Fellowship: Pediatric Pulmonology, Tulane Medical Center, New Orleans LA, 2003; Sleep Medicine, Cincinnati Children's Hospital, Cincinnati OH, 2008.
Certification: Pediatrics, 2000, recertified 2007; Pediatric Pulmonology, 2004.
Marc G. Schecter, MD Medical Director, Pediatric Lung Transplant Program 513-636-6771 firstname.lastname@example.org
Medical Director, Pediatric Lung Transplant Program
MD: University of Texas Medical Branch, Galveston, TX, 2000.
Residency: University of Texas Health Science Center, Houston, TX, 2003.
Fellowship: University of Texas Health Science Center, Houston, TX, 2006.
Certifications: Pediatrics, 2003; Pediatric Pulmonary, 2006.
Yousef S, Benden C, Boyer D, Elidemir O, Frischer T, Goldfarb S, Lopez-Mitnik G, Mallory G, Visner G, Westall G, Schecter MG. Lung transplantation in children following bone marrow transplantation: a multi-center experience. Pediatric Transplant. 2013 May;17(3):231-6.
Khan MS, Heinle JS, Samayoa AX, Adachi I, Schecter MG, Mallory GB, Morales DL. Is lung transplantation survival better in infants? Analysis of over 80 infants. J Heart Lung Transplant. 2013 Jan;32(1):44-9.
Rama JA, Fan LL, Faro A, Elidemir O, Morales DL, Heinle JS, Smith EO, Hazen ML, Moonnumakal SP, Mallory GB, Schecter MG. Lung Transplantation for childhood diffuse lung disease. Pediatr Pulmonol. 2013 May;48(5):490-6.
Vece TJ, Schecter MG, Gatti RA, Tunuguntla R, Garcia CK, Langston C, Dishop MK, Moore RH, Fan LL. Rapid and progressive pulmonary fibrosis in 2 families with DNA repair deficiencies of undetermined etiology. J Pediatr. 2012 Apr;160(4):700-702.e3.
Schaellibaum G, Lammers AE, Faro A, Moreno-Galdo A, Parakininkas D, Schecter MG, Solomon M, Boyer D, Conrad C, Frischer T, Wong J, Boehler A, Benden C. Bilateral lung transplantation for pediatric idiopathic pulmonary arterial hypertension: a multi-center experience. Pediatr Pulmonol. 2011 Nov;46(11):1121-7.
Scully BB, Zafar F, Schecter MG, Rossano JW, Mallory GB Jr, Heinle JS, Morales DL. Lung Retransplant in Children: appropriate when selectively applied. Ann Thorac Surg. 2011 Feb;91(2):574-9.
Rosen JB, Schecter MG, Heinle JS, McKenzie ED, Morales DL, Dishop MK, Danziger-Isakov L, Mallory GB, Elidemir O. Clostridium Difficile colitis in children following lung transplantation. Pediatr Transplant. 2010 Aug;14(5):651-6.
Michael Seid, PhD Director, Health Outcomes and Quality Care Research, Pulmonary Medicine and James M. Anderson Center for Health Systems Excellence 513-803-0083 email@example.com
Director, Health Outcomes and Quality Care Research, Pulmonary Medicine and James M. Anderson Center for Health Systems Excellence
Health care quality and outcomes
Visit the Seid Lab.
Michael Seid, PhD, is director of Health Outcomes and Quality of Care Research in the Division of Pulmonary Medicine and a core faculty in the James M. Anderson Center for Health Systems Excellence at Cincinnati Children's Hospital Medical Center within the UC Department of Pediatrics. Dr. Seid applies behavioral and social science to the question ‘What does it take to make sure the right treatment gets to the right child in the right way at the right time, every time?’
Dr. Seid has worked at the Center for Child Health Outcomes at Children's Hospital, San Diego and was a behavioral / research scientist at the RAND Corporation. He has been principal and co-principal investigator of several large multidisciplinary research studies, collaborates with investigators at Cincinnati Children's and beyond, and publishes widely in such journals as Medical Care, HSR: Health Services Research, Archives of Pediatrics and Adolescent Medicine, Pediatrics, American Journal of Medical Quality, the Journal of Ambulatory Pediatrics, and Milbank Quarterly.
Dr. Seid has served as the chair of Children's Hospital San Diego's Institutional Review Board, as a member of the Health Care Quality and Effectiveness Research (HCQER) Study Section at the Agency for Healthcare Quality and Research, and on several national and local expert panels. He is on the Review Board of the Journal of Clinical Outcomes Management and an ad hoc reviewer for Health Services Research, Pediatrics and the Journal of Ambulatory Pediatrics.
Grossoehme DH, Ragsdale JR, Snow A, Seid M. We were Chosen as a Family: Parents' Evolving Use of Religion when Their Child has Cystic Fibrosis. J Relig Health. 2011 Mar 16.
Muething SE, Conway PH, Kloppenborg E, Lesko A, Schoettker PJ, Seid M, Kotagal U. Identifying causes of adverse events detected by an automated trigger tool through in-depth analysis. Qual Saf Health Care. 2010 Oct;19(5):435-9.
Grossoehme DH, Ragsdale J, Cotton S, Wooldridge JL, Grimes L, Seid M. Parents' religious coping styles in the first year after their child's cystic fibrosis diagnosis. J Health Care Chaplain. 2010 Jul;16(3-4):109-22.
Grossoehme DH, Ragsdale J, Wooldridge JL, Cotton S, Seid M. We can handle this: parents' use of religion in the first year following their child's diagnosis with cystic fibrosis. J Health Care Chaplain. 2010 Jul;16(3-4):95-108.
Stevens GD, Seid M, Pickering TA, Tsai KY. National disparities in the quality of a medical home for children. Matern Child Health J. 2010 Jul;14(4):580-9.
Ernst MM, Wooldridge JL, Conway E, Dressman K, Weiland J, Tucker K, Seid M. Using Quality Improvement Science to Implement a Multidisciplinary Behavioral Intervention Targeting Pediatric Inpatient Airway Clearance. J Pediatr Psychol. 2010 Jan-Feb; 35(1):1.
Seid M, Limbers CA, Driscoll KA, Opipari-Arrigan LA, Gelhard LR, & Varni JW. Reliability, validity, and responsiveness of the Pediatric Quality of Life Inventory™ (PedsQL™) Generic Core Scales and Asthma Symptoms Scale in vulnerable children with asthma. Journal of Asthma. 2010;47:170-177.
Wirtschafter DD, Pettit J, Kurtin P, Dalsey M, Chance K, Morrow HW, Seid M, Byczkowski TL, Huber TP, Milstein JM, Bowles SM, Fichera S, Kloman S. A statewide quality improvement collaborative to reduce neonatal central line-associated blood stream infections. J Perinatol. 2010 Mar;30(3):170-81.
Fairbrother G, Cassedy A, Ortega-Sanchez IR, Szilagyi PG, Edwards KM, Molinari NA, Donauer S, Henderson D, Ambrose S, Kent D, Poehling K, Weinberg GA, Griffin MR, Hall CB, Finelli L, Bridges C, Staat MA; New Vaccine Surveillance Network (NVSN). High costs of influenza: Direct medical costs of influenza disease in young children. Vaccine. 2010 Jul 12;28(31):4913-9.
Narong Simakajornboon, MD Director, Sleep Disorders Center 513-636-6771 firstname.lastname@example.org
Director, Sleep Disorders Center
Director, Sleep Medicine Fellowship Program
Pediatric sleep disorders; respiratory control disorders
MD: Faculty of Medicine, Siriraj Hospital, Mahidol University, Thailand, 1992.
Residency: Pediatrics, Children's Hospital of Michigan, Detroit, MI.
Fellowship: Pediatric Pulmonology and Sleep Medicine, Tulane University School of Medicine, New Orleans, LA.
Jain SV, Simakajornboon S, Shapiro SM, Morton LD, Leszczyszyn DJ, Simakajornboon N. Obstructive sleep apnea in children with epilepsy: prospective pilot trial. Acta Neurol Scand. 2011 Mar 17.
Bhattacharjee R, Kheirandish-Gozal L, Spruyt K, Mitchell RB, Promchiarak J, Simakajornboon N, Kaditis AG, Splaingard D, Splaingard M, Brooks LJ, Marcus CL, Sin S, Arens R, Verhulst SL, Gozal D. Adenotonsillectomy outcomes in treatment of obstructive sleep apnea in children: a multicenter retrospective study. Am J Respir Crit Care Med. 2010 Sep 1;182(5):676-83.
Ednick M, Cohen AP, McPhail GL, Beebe D, Simakajornboon N, Amin RS. A review of the effects of sleep during the first year of life on cognitive, psychomotor, and temperament development. Sleep. 2009 Nov 1;32(11):1449-58.
Ednick M, Tinkle BT, Phromchairak J, Egelhoff J, Amin R, Simakajornboon N. Sleep-related respiratory abnormalities and arousal pattern in achondroplasia during early infancy. J Pediatr. 2009 Oct;155(4):510-5.
Reeves SR, Simakajornboon N, Gozal D. The role of nitric oxide in the neural control of breathing. Respir Physiol Neurobiol. 2008 Dec 10;164(1-2):143-50.
Naqvi SK, Sotelo C, Murry L, Simakajornboon N. Sleep architecture in children and adolescents with cystic fibrosis and the association with severity of lung disease. Sleep Breath. 2008 Mar;12(1):77-83.
Simakajornboon N. Periodic limb movement disorder in children. Paediatr Respir Rev. 2006;7 Suppl 1:S55-7.
Simakajornboon N, Kuptanon T. Maturational changes in neuromodulation of central pathways underlying hypoxic ventilatory response. Respir Physiol Neurobiol. 2005 Nov 15;149(1-3):273-86.
Baber SR, Li H, Simakajornboon N, Kadowitz PJ, Ross-Ascuitto NT, Ascuitto RJ. Analysis of pulmonary vascular response to acute alveolar hypoxic challenge in young rabbits subjected to chronic hypoxia from birth. J Cardiovasc Pharmacol. 2005 May;45(5):431-8.
Simakajornboon N, Vlasic V, Li H, Sawnani H. Effect of prenatal nicotine exposure on biphasic hypoxic ventilatory response and protein kinase C expression in caudal brain stem of developing rats. J Appl Physiol. 2004 Jun;96(6):2213-9.
Christopher Siracusa, MD 513-636-6771 email@example.com
MD: American University of the Caribbean, Netherlands, Antilles, 2009.
Residency: Akron Children’s Hospital/NEOUCOM, Akron, OH, 2012.
Rhonda D. Szczesniak, PhD 513-803-0563 firstname.lastname@example.org
PhD: Statistics, University of Kentucky, Lexington, KY, 2007.
MS: Statistics, University of Kentucky, Lexington, KY, 2005.
BS: Mathematics, Radford University, Radford, VA, 2003.
Grossoehme DH, Szczesniak R, Dodd C, Opipari-Arrigan L. Dyadic Adjustment and Spiritual Activities in Parents of Children with Cystic Fibrosis. Religions. Jun 2014;5(2):385-401.
Tan CC, McDowell KM, Fenchel M, Szczesniak R, Kercsmar CM. Spirometry Use in Children Hospitalized With Asthma. Pediatr Pulmonol. May 2014;49(5):451-457.
Szczesniak RD, McPhail GL, Duan LL, Macaluso M, Amin RS, Clancy JP. A semiparametric approach to estimate rapid lung function decline in cystic fibrosis. Annals of epidemiology. Dec 2013 2013;23(12):771-777.
Clancy JP, Szczesniak RD, Ashlock MA, et al. Multicenter Intestinal Current Measurements in Rectal Biopsies from CF and Non-CF Subjects to Monitor CFTR Function. PLoS One. Sep 2013;8(9):13.
Cudzilo CJ, Szczesniak RD, Brody AS, et al. Lymphangioleiomyomatosis Screening in Women With Tuberous Sclerosis. Chest. Aug 2013;144(2):578-585.
Pediatric Sleep Research Program. Biostatistics Mentor. K24 NIH/NHLBI. March 2011-Feb 2016.
MR predictors of infection, inflammation, and structural lung damage in CF. Biostatistician. R01 NIH. Sep 2012-June 2016.
Cherie Torres-Silva, MD, MPH 513-636-6771 email@example.com
Christopher Towe, MD Director, Rare Lung Diseases Program 513-636-6771 firstname.lastname@example.org
Director, Rare Lung Diseases Program
Childhood interstitial lung diseases; lung transplantation
MD: University of Texas Southwestern School of Medicine, Dallas, TX, 2008.
Residency: Pediatrics, St. Louis Children's Hospital, St. Louis, MO, 2011.
Fellowship: Pediatric Pulmonary, Washington University School of Medicine, St. Louis, MO, 2014.
Certification: Pediatric Pulmonary, 2014; Pediatrics, 2012.
Mahmoud M, Towe C, Fleck R. CT chest under general anesthesia: pulmonary, anesthetic and radiologic dilemmas. Pediatr Radiol. 2014 Dec.
Towe C, Ogborn AC, Ferkol T, Sweet S, Huddleston C, White F, Faro A. Bronchiolitis obliterans syndrome is not specific for bronchiolitis obliterans in pediatric lung transplant. J Heart and Lung Transplantation. 2014 Nov.
Szafranski P, Dharmadhikari AV, Wambach JA, Towe CT, White FV, Grady RM, Eghtesady P, Cole FS, Deutsch G, Sen P, Stankiewicz P. Two deletions overlapping a distant FOXF1 enhancer unravel the role of lncRNA LINC01081 in etiology of alveolar capillary dysplasia with misalignment of pulmonary veins. Am J Med Genet A. 2014 Aug;164A(8):2013-9.
Bruce C. Trapnell, MS, MD Assistant Director, Adult Cystic Fibrosis Center 513-636-6361 email@example.com
Assistant Director, Adult Cystic Fibrosis Center
Pulmonologist - Research, Adult Clinical, Division of Pulmonary Medicine
Pulmonary alveolar proteinosis; cystic fibrosis; alpha-1 antitrypsin deficiency; other rare lung disorders
Bruce Trapnell, MS, MD, received his medical degree from the University of Maryland in 1985, and completed a medical residency at The Ohio State University Hospitals and a fellowship in pulmonary medicine at the Clinical Center of the National Institutes of Health, where he then served as senior attending physician. Subsequently, he established the Division of Pulmonary and Virology Studies at Genetic Therapy, Inc., a subsidiary of Novartis, Pharma, serving as vice president before joining Cincinnati Children’s Hospital Medical Center, where he is now full professor for the UC College of Medicine.
Dr. Trapnell has conducted lung disease research since his training and has been continuously funded by the NIH since 2001, shortly after his arrival in Cincinnati. He has published over 90 original articles and has trained more than 16 post-doctoral fellows. Dr. Trapnell’s research interests are focused to the pathogenesis and therapy of rare lung diseases and mechanisms by which GM-CSF regulates innate immunity and lung host defense.
Dr. Trapnell is director of Cincinnati’s Cystic Fibrosis Therapeutics Development Network Center, assistant director of the Adult Cystic Fibrosis Care Center, director of the Rare Lung Diseases Clinical Research Consortium, scientific director of the Pulmonary Alveolar Proteinosis Foundation. Dr. Trapnell is the past scientific director of the Alpha-1 Foundation, for which he organized and directed the grant program for eight years.
MS: Genetics, The George Washington University, Washington, DC, 1981.
MD: University of Maryland School of Medicine, Baltimore, MD, 1984.
Residency: Internal Medicine, The Ohio State University Hospitals, Columbus, OH, 1987.
Fellowship: Pulmonary Medicine, Warren Grant Magnuson Clinical Center, National Institutes of Health, Bethesda, MD, 1989.
Certification: Diplomate in Internal Medicine, American Board of Internal Medicine, 1987; Diplomate, National Board of Medical Examiners, 1987; Diplomate in Pulmonary Medicine, American Board of Internal Medicine, 2000.
Wu H, Suzuki T, Carey B, Trapnell BC, McCormack FX. Keratinocyte growth factor (KGF) augments pulmonary innate immunity through epithelium-driven, GM-CSF dependent paracrine activation of alveolar macrophages. J Biol Chem. 2011 Feb 22.
D'Mello S, Trauernicht A, Ryan A, Bonkowski E, Willson T, Trapnell BC, Frank SJ, Kugasathan S, Denson LA. Innate dysfunction promotes linear growth failure in pediatric Crohn's disease and growth hormone resistance in murine ileitis. Inflamm Bowel Dis. 2011 Feb 18.
Suzuki T, Sakagami T, Young LR, Carey BC, Wood RE, Luisetti M, Wert SE, Rubin BK, Kevill K, Chalk C, Whitsett JA, Stevens C, Nogee LM, Campo I, Trapnell BC. Hereditary pulmonary alveolar proteinosis: pathogenesis, presentation, diagnosis, and therapy. Am J Respir Crit Care Med. 2010 Nov 15;182(10):1292-304.
Young LR, Vandyke R, Gulleman PM, Inoue Y, Brown KK, Schmidt LS, Linehan WM, Hajjar F, Kinder BW, Trapnell BC, Bissler JJ, Franz DN, McCormack FX. Serum vascular endothelial growth factor-D prospectively distinguishes lymphangioleiomyomatosis from other diseases. Chest. 2010 Sep;138(3):674-81.
Han X, Gilbert S, Groschwitz K, Hogan S, Jurickova I, Trapnell B, Samson C, Gully J. Loss of GM-CSF signalling in non-haematopoietic cells increases NSAID ileal injury. Gut. 2010 Aug;59(8):1066-78.
Sakagami T, Beck D, Uchida K, Suzuki T, Carey BC, Nakata K, Keller G, Wood RE, Wert SE, Ikegami M, Whitsett JA, Luisetti M, Davies S, Krischer JP, Brody A, Ryckman F, Trapnell BC. Patient-derived granulocyte/macrophage colony-stimulating factor autoantibodies reproduce pulmonary alveolar proteinosis in nonhuman primates. Am J Respir Crit Care Med. 2010 Jul 1;182(1):49-61.
Carey B, Trapnell BC. The molecular basis of pulmonary alveolar proteinosis. Clin Immunol. 2010 May;135(2):223-35.
Trapnell BC, Maguiness K, Graff GR, Boyd D, Beckmann K, Caras S. Efficacy and safety of Creon 24,000 in subjects with exocrine pancreatic insufficiency due to cystic fibrosis. J Cyst Fibros. 2009 Dec;8(6):370-7.
Trapnell BC, Carey BC, Uchida K, Suzuki T. Pulmonary alveolar proteinosis, a primary immunodeficiency of impaired GM-CSF stimulation of macrophages. Curr Opin Immunol. 2009 Oct;21(5):514-21.
Uchida K, Nakata K, Suzuki T, Luisetti M, Watanabe M, Koch DE, Stevens CA, Beck DC, Denson LA, Carey BC, Keicho N, Krischer JP, Yamada Y, Trapnell BC. Granulocyte/macrophage-colony-stimulating factor autoantibodies and myeloid cell immune functions in healthy subjects. Blood. 2009 Mar 12;113(11):2547-56.
Robert E. Wood, PhD, MD Director, Pulmonary Bronchoscopy Department 513-636-6771 firstname.lastname@example.org
Director, Pulmonary Bronchoscopy Department
Dr. Robert Wood, PhD, MD, is a pediatric pulmonary specialist, with particular interest in bronchoscopy. He has played a major role in the development of instrumentation and techniques for flexible bronchoscopy in pediatric patients. He is recognized as a teacher of endoscopic techniques, and has published many papers and book chapters on the subject. Additionally, he has extensive experience with clinical problems in pediatric pulmonary medicine, especially children with complex airway problems and cystic fibrosis.
Before coming to Cincinnati Children's Hospital Medical Center, Dr. Wood was on the faculty of Case Western Reserve University in Cleveland, Ohio (1976 to 1983), and the University of North Carolina at Chapel Hill (1983 to 1999).
PhD: Medical Physiology, Vanderbilt University, Nashville, TN, 1968.
MD: Vanderbilt University, Nashville, TN, 1970.
Residency: Pediatrics, Duke University Medical Center, Durham, NC, 1970 to 1972.
Fellowship: Pediatric Metabolism, National Institute of Arthritis, Metabolism, and Digestive Diseases, Bethesda, MD, 1972 to 1974; Pediatric Pulmonology, Case Western Reserve University, Cleveland, OH; Rainbow Babies and Children's Hospital, Cleveland, OH, 1974 to 1976.
Certification: Pediatrics, 1976; Pediatric Pulmonology, 1986, 1997.
Abman S, Jobe A, Chernick V, Blaisdell C, Castro M, Ramirez MI, Gern JE, Cutting G, Redding G, Hagood JS, Whitsett J, Abman S, Raj JU, Barst R, Kato GJ, Gozal D, Haddad GG, Prabhakar NR, Gauda E, Martinez FD, Tepper R, Wood RE, Accurso F, Teague WG, Venegas J, Cole FS, Wright RJ, Gail D, Hamvas A, Kercsmar C, Kiley J, Weinmann G; NHLBI working group report. Strategic plan for pediatric respiratory diseases research: an NHLBI working group report. Pediatr Pulmonol. 2009 Jan;44(1):2-13.
Muenzer J, Beck M, Eng CM, Escolar ML, Giugliani R, Guffon NH, Harmatz P, Kamin W, Kampmann C, Kosepglu ST, Link B, Martin RA, Molter DW, MuAoz Rojas MV, Ogilvie JW, Parini R, Ramaswami U, Scarpa M, Schwartz IV, Wood RE, Wraith E. Multidisciplinary Management of Hunter Syndrome. Pediatrics. 2009; 124:e1228-39.
Suzuki T, Sakagami T, Rubin BK, Nogee LM, Wood RE, Zimmerman SL, Smolarek T, Dishop MK, Wert SE, Whitsett JA, Grabowski G, Carey BC, Stevens C, van der Loo JC, Trapnell BC. Familial pulmonary alveolar proteinosis caused by mutations in CSF2RA. J Exp Med. 2008 Nov 24;205(12):2703-10.
Wood RE. Evaluation of the upper airway in children. Curr Opin Pediatr. 2008 Jun;20(3):266-71. Review.
Boesch RP, Daines C, Willging JP, Kaul A, Cohen AP, Wood RE, Amin RS. Advances in the diagnosis and management of chronic pulmonary aspiration in children. Eur Respir J. 2006 Oct;28(4):847-61. Review.
Zur KB, Wood RE, Elluru RG. Pediatric postcricoid vascular malformation: a diagnostic and treatment challenge. Int J Pediatr Otorhinolaryngol. 2005 Dec;69(12):1697-701.
Lim LH, Cotton RT, Azizkhan RG, Wood RE, Cohen AP, Rutter MJ. Complications of metallic stents in the pediatric airway. Otolaryngol Head Neck Surg. 2004 Oct;131(4):355-61.
Wood RE. The emerging role of flexible bronchoscopy in pediatrics. Clin Chest Med. 2001 Jun;22(2):311-7, viii. Review.
Jason C. Woods, PhD Director, Center for Pulmonary Imaging Research 513-803-4463 email@example.com
Director, Center for Pulmonary Imaging Research
Hyperpolarized gas; pulmonary MRI; translational studies; image-guided pulmonary interventions
Dr. Woods is one of the world’s leading experts on hyperpolarized-gas MRI and the use of such gas MRI to measure regional lung function, microstructure and physiology. He began his career at Washington University, where he helped lead multiple team projects related to lung imaging, biology and physiology. Interests in both world-class science and higher education led him to pursue simultaneous roles as a professor and academic dean, when he became program director for Washington University’s MARC (T34) training program.
Currently Dr. Woods directs the Center for Pulmonary Imaging Research at Cincinnati Children’s Hospital Medical Center. The center is a multidisciplinary research and training program at the intersection of pulmonary medicine and radiology.
PhD: Washington University, St. Louis, MO, 2002.
Postdoctoral: Washington University, St. Louis, MO, 2004.
Walkup LL, Tkach JA, Higano NS, Thomen RP, Fain SB, Merhar SL, Fleck RJ, Amin RS, Woods JC. Quantitative magnetic resonance imaging of bronchopulmonary dysplasia in the NICU environment. Am J Respir Crit Care Med. 2015 Jul 17.
Walkup LL, Woods JC. Newer Imaging techniques for BPD. Clinics in Perinatology. 2015.
Young SM, Liu S, Rashika J, Batie M, Kofron M, Guo J, Woods JC, Varisco B. Localization and stretch-dependence of elastin remodeling in lung development and compensatory regrowth. J Appl Physiol. 2015;118:921-931.
Li Y, Wang H, Tkach J, Roach D, Woods J, Dumoulin C. Wavelet-space Correlation Imaging for High-speed MRI without Motion Monitoring or Data Segmentation. Magn Reson Med. 2015.
Guo J, Huang HJ, Wang X, Wang W, Ellison H, Thomen RP, Gelman AE, Woods JC. Imaging mouse lung allograft rejection with 1H MRI. Magn Reson Med. 2015;274:250-9.
Thomen RP, Sheshadri A, Quirk JD, Kozlowski J, Ellison HD, Castro M, Woods JC. Regional ventilation changes in severe asthma after bronchial thermoplasty by 3He MRI and CT. Radiology. 2015;573:1970-8.
Walkup L, Woods JC. Translational Applications of Hyperpolarized 3He and 129Xe. NMR Biomed. 2014;27:1429-38.
Pennati F, Salito C, Baroni G, Woods JC, Aliverti A. Comparison Between Multivolume CT-Based Surrogates of Regional Ventilation in Healthy Subjects. Acad Rad. 2014;21:1268-75.
Pennati F, Quirk JD, Yablonskiy DA, Castro M, Aliverti A, Woods JC. Assessment of regional lung function by multi-volume 1H-MRI in health and obstructive lung disease: comparison with 3He-MRI. Radiology. 2014;273:580-90.
Phillipot Q, Deslée G, Adair-Kirk T, Woods JC, Byers D, Dury S, Perotin Collard J-M, Lebargy F, Cassan C, Le Naour R, Holtzman MJ, Pierce RA. Increased iron sequestration in alveolar macrophages in chronic obstructive pulmonary disease. Plos One. 2014;9:e96285.
Salito C, Barazzetti L, Woods J, Aliverti A. Heterogeneity of Specific Gas Volume Changes: a New Tool to Plan Lung Volume Reduction in Emphysema. Chest. 2014;146:1554-65.
Chang YV, Quirk JD, Ruset IC, Atkinson JJ, Hersman FW, Woods JC. Quantification of human lung structure and physiology using hyperpolarized 129Xe. Magn Reson Med. 2014;71:339-344.
Nanhua Zhang, PhD 513-803-9108 firstname.lastname@example.org
Missing data; comparative effectiveness; clinical trial design; meta-analysis; scale development; joint modeling; environmental health; community-based intervention; health disparity; behavioral intervention; health psychology
Dr. Zhang earned his PhD in biostatistics from the University of Michigan in Ann Arbor. Prior to joining Cincinnati Children’s Hospital Medical Center, he was a faculty member at the University of South Florida in Tampa. His statistical methodology research has covered missing data, causal inference, clinical trial design, joint modeling and meta-analysis. His applied research interests include environmental health, community-based intervention, health disparity, behavioral intervention and health psychology. His research “early childhood lead exposure on academic achievement” received media coverage on TV, radio, newspapers, magazines, and various online media such as Time.com and Yahoo.com.
Dr. Zhang has authored 20 published papers and made numerous presentations at national and international conferences. He has served as a reviewer for 15 different journals including: Biometrika, Statistics in Medicine, Statistics Sinica, Annals of Applied Statistics, American Journal of Public Health, Annals of Epidemiology, Health Education Research. He has taught graduate and advanced doctoral courses in linear models, survival analysis and statistical computing.
BS: Shanghai University of Finance and Economics, Shanghai, China.
MS: Bowling Green State University, Bowling Green, OH.
PhD: University of Michigan, Ann Arbor, MI.
Zhang N, Little RJA. Subsample ignorable likelihood for accelerated failure time models with missing predictors. Lifetime Data Anal. 2014 Aug 5.
Huang Y, Xing D, Zhang N, Chen H. Jointly Modeling Event Time and Skewed-Longitudinal Data with Missing Response and Mismeasured Covariate. J Biopharm Stat. 2014 Jun 6.
Zhang N, Chen H, Zou Y. A joint model of binary and longitudinal data with non-ignorable missingness, with application to marital stress and late life depression. J Applied Statistics. 2014;41(5);1028-39.
Brannick MT, Zhang N. Bayesian Meta-analysis of Coefficient Alpha. Res Synthesis Methods. 2013;4(2):198-207.
Chen H, Zhang N, Lu X, Chen S. Caution regarding the choice of standard deviations to guide sample size calculations in clinical trials. Clin Trials. 2013 Aug;10(4)522-9.
Zhang N, Baker HW, Tufts M, Raymond RE, Salihu H, Elliott MR. Early childhood lead exposure and academic achievement: evidence from Detroit Public Schools (2008-2010). Am J Public Health. 2013 Mar;103(3):e72-7.
Zhang N, Little RJA. A pseudo-Bayesian approach to regression with missing covariates. Biometrics. 2012 Sep;68(3):933-42.
Little RJA, Zhang N. Subsample ignorable likelihood for regression with missing data. J R Stat Soc Ser C Appl Stat. 2011;60, 591-605.
Resnicow K, Zhang N, Vaughan R, Reddy SP, James S, Murry DM. When intraclass correlation coefficients go awry: a case study from a school-based smoking prevention study in South Africa. Am J Public Health. 2010 Sep;100(9):1714-48.
Resnicow K, Davis RE, Zhang N, Strecher VJ, Tolsma D, Calvi J, Alexander G, Anderson JP, Wiese C. Tailoring a fruit and vegetable intervention on ethnic identity: results of a randomized study. Health Psychol. 2009 Jul;28(4):394–403.
Assem G. Ziady, PhD Director, The Cystic Fibrosis Biomarker Analysis and Assay Development RDP Core 513-803-9094 email@example.com
Director, The Cystic Fibrosis Biomarker Analysis and Assay Development RDP Core
Associate Professor, Case Western Reserve University
Cystic fibrosis; redox mediated inflammatory signaling; nonviral gene transfer to the lung; biomarkers of disease severity and response to therapy.
Dr. Ziady received his undergraduate education at Boston College in biochemistry in 1993. He completed his graduate studies on cell physiology and received his PhD degree in 1999 from Case Western Reserve University. Following his postdoctoral training at the Department of Pediatrics at Case Western Reserve University, he began a year-long externship at the Cleveland Clinic Proteomic facility in early 2002. In 2003, Dr. Ziady joined the faculty at the Case Western Reserve University Department of Pediatrics as assistant professor. In 2011, Dr. Ziady joined the faculty at the Emory University Department of Pediatrics as an associate professor and served as the associate director of Cystic Fibrosis Basic & Translational Research at Emory University.
In 2014, Dr. Ziady was recruited by the CF program at Cincinnati Children’s Hospital Medical Center, where he joined the faculty as associate professor of pediatrics within the UC College of Medicine in November. Dr. Ziady’s research has been supported by the State of Ohio, the Cystic Fibrosis Foundation, and the National Institutes of Health. His laboratory focuses on the differential regulation of Nrf2 signaling pathways in the inflammatory lung disease observed cystic fibrosis. Dr. Ziady's lab also has unique expertise in developing and characterizing DNA nanoparticles for nonviral gene delivery to the lung, liver, and brain. Finally, Dr. Ziady’s lab has expertise in proteomic analyses for biomarker discovery and the examination of systems biology of various tissues. He is an inventor on five patents (2 USA, 2 EU, and 1 international) pertaining to DNA nanoparticles, and one provisional patent pertaining to modulation of inflammatory signaling. In the past 15 years, he has authored 33 manuscripts and book chapters, has an h-index of 19, and has been invited to present 42 talks on his work at national and international conferences and institutions.
BS: Biochemistry, Boston College, Boston, MA, 1993.
PhD: Cell Physiology, Physiology and Biophysics, Case Western Reserve University, Cleveland, OH, 1999.
Postdoctoral Fellowship: Non-viral gene transfer, Pediatrics, Case Western Reserve University, Cleveland, OH, 2002.
Externship: Proteomic analysis of redox mediated inflammation in CF, Cell Biology, Cleveland Clinic Foundation, Cleveland, OH, 2003.
Ziady AG, Hansen J. Redox balance in Cystic Fibrosis. Int J Biochem Cell Biol. 2014 Jul;52:113-23.
Cheng Y, Doane TL, Chuang CH, Ziady A, Burda C. Near infrared light-triggered drug generation and release from gold nanoparticle carriers for photodynamic therapy. Small. 2014;10(9):1799-1804. (Joint corresponding author with C. Burda).
Ziady AG, Sokolow A, Shank S, Corey D, Myers R, Plafker S, Kelley TJ. Interaction with CREB binding protein modulates the activities of Nrf2 and NF-κB in Cystic Fibrosis Airway epithelial cells. Am J Physiol Lung Cell Mol Physiol. 2012;302(11):L1221-1231.
Yurek DM, Fletcher AM, McShane M, Kowalczyk TH, Padegimas L, Weatherspoon MR, Kaytor MD, Cooper MJ, Ziady AG. DNA Nanoparticles: Detection of long-term transgene activity in brain using bioluminescence imaging. Mol Imaging. 2011;10(5):327-339.
Lancioni CL, Li Q, Thomas JJ, Ding X, Thiel B, Drage MG, Pecora ND, Ziady AG, Shank S, Harding CV, Boom WH, Rojas RE. Mycobacterium tuberculosis lipoproteins induce human memory CD4+ T cell activation via toll-like receptors 1 and 2. Infect and Immun. 2011;79(2):663-673.
Chen X, Shank S, Davis PB, Ziady AG. Nucleolin-mediated cellular trafficking of DNA nanoparticle is lipid raft and microtubule dependent and can be modulated by glucocorticoid. Molec Ther. 2011;19(1):93-102.
Ziady AG, Kotlarchyk M, Bryant L, McShane M, Lee Z. Bioluminescent imaging of reporter gene expression in the lungs of wildtype and model mice following the administration of PEG-stabilized DNA nanoparticles. Microsc Res Tech. 2010;73(9):918-928.
Nichols DP, Ziady AG, Shank SL, Eastman JF, Davis PB. The Triterpenoid CDDO limits inflammation in preclinical models of Cystic Fibrosis lung disease. Am J Physiol Lung Cell Mol Physiol. 2009;297(5):L828-836.
Yurek DM, Fletcher AM, Smith GM, Seroogy KB, Ziady AG, Molter J, Kowalczyk TH, Padegimas L, Cooper MJ. Long-term transgene expression in the Central Nervous System using DNA nanoparticles. Mol Ther. 2009;17(4):641-650.
Chen J, Kinter M, Shank S, Cotton C, Kelley TJ, Ziady AG. Dysfunction of Nrf-2 in CF epithelia leads to excess intracellular H2O2 and inflammatory cytokine production. PLoS ONE. 2008;3(10):e3367.
Nrf2 dysfunction in CF epithelia. Principal Investigator. National Institutes of Health/National Heart, Lung, and Blood Institute. Jul 2011-Jun 2016. 5R01HL109362.
MR predictors of infection, inflammation, and structural damage in CF. Contract Principal Investigator. National Institutes of Health/National Heart, Lung, and Blood Institute. Sep 2012-Jun 2017. 1R01HL116226.
CFF CCHMC Research Development Program. Principal Investigator. Cystic Fibrosis Foundation. Jul 2015-Jun 2019.
Gilead Sciences Research Grant. Contract Principal Investigator. Gilead Sciences. Jul 2014-Jun 2016.
Jamie L. Miller, MSW, LISW
Social Worker, Cystic Fibrosis, Division of Pulmonary Medicine 513-803-1814 firstname.lastname@example.org
Susan Moore, MSW, LISW
Social Worker, Cystic Fibrosis, Division of Pulmonary Medicine 513-636-6771 email@example.com
Andrea L. O'Brien, PhD, MSW, LSW
Social Worker II, Division of Social Services 513-636-6771 firstname.lastname@example.org
Rachel A. Sackenheim, MSW, LISW-S
Pulmonary Social Worker, Division of Pulmonary Medicine 513-636-6771 email@example.com
John J. Brewington, MD Clinical Fellow, Division of Pulmonary Medicine 513-636-6771 firstname.lastname@example.org
Clinical Fellow, Division of Pulmonary Medicine
Pediatrics; pediatric pulmonology
John Brewington is a clinical fellow for the Division of Pulmonary Medicine at Cincinnati Children’s Hospital Medical Center. He studied English and biology, then medicine at Wake Forest University, and completed his pediatric residency at Cincinnati Children's. He plans to pursue a career in pediatric pulmonology, beginning with a pulmonary medicine fellowship at Cincinnati Children's starting in 2013. During his time as a medical student and resident, John has become a member of AΩA and the Gold Humanism in Medicine Society, and was the recipient of the Samuel Dalinsky Memorial Award and the Thomas F. Boat Pediatric Pulmonology Award.
MD: Wake Forest University, Winston-Salem, NC, 2009.
Residency: Pediatrics, Cincinnati Children’s Hospital, Cincinnati, OH.
Certification: Pediatrics, 2012 (pending).
Gregory Burg, MD Clinical Fellow, Division of Pulmonary Medicine 513-636-6771 email@example.com
BA: Chemistry, Washington & Jefferson College, Washington, PA, 2005.
MD: Joan C. Edwards School of Medicine (Marshall University), Huntington, WV, 2011.
Residency: Internal Medicine and Pediatrics, LSU Health Sciences Center, New Orleans, LA, 2015.
Zarmina Ehsan, MB, BS Sleep Fellow, Division of Pulmonary Medicine 513-636-6771 firstname.lastname@example.org
Sleep Fellow, Division of Pulmonary Medicine
MD: Aga Kha Medical College, Pakistan, 2007.
Residency: Indiana University, Indianapolis, IN, 2012.
Certification: Pediatrics, 2012.
Fellowship: Pediatric Pulmonology, Cincinnati Children's Hospital Medical Center, 2012-2015.
Fellowship: Sleep Medicine.
Ehsan Z, Nathan JD, Kercsmar CM. An infant with a hyperlucent chest mass: An unexpected diagnosis. Pediatr Pulmonol. 2015 Jul 23.
Ehsan Z, Mahmoud M, Shott SR, Amin RS, Ishman SL. The effects of Anesthesia and opioids on the upper airway: A systematic review. Laryngoscope. 2015 Jul 21.
McPhail GL, Ehsan Z, Howells SA, Boesch RP, Fenchel MC, Szczesniak R, Jain V, Agabegi S, Sturm P, Wall E, Redding GJ. Obstructive lung disease in children with idiopathic scoliosis. J Pediatr. 2015 Apr;166(4):1018-21.
Ehsan Z, Clancy J. T100: nebulized-concentrated tobramycin formulation for treatment of Pseudomonas aeruginosa infection in cystic fibrosis patients. Expert Opinion on Orphan Drugs. 2015;3(8):933-943.
Ehsan Z, Wetzel JD, Clancy JP. Nebulized liposomal amikacin for the treatment of Pseudomonas aeruginosa infection in cystic fibrosis patients. Expert Opin Investig Drugs. 2014 May;23(5):743-9.
Ehsan Z, Montgomery GS, Tiller C, Kisling J, Chang DV, Tepper RS. An infant with pulmonary interstitial glycogenosis: clinical improvement is associated with improvement in the pulmonary diffusion capacity. Pediatr Pulmonol. 2014 Mar;49(3):E17-20.
Elizabeth L. Kramer, MD, PhD Clinical Fellow, Division of Pulmonary Medicine 513-636-6771 email@example.com
Developmental biology; pulmonology
MD: University of Cincinnati, Cincinnati, OH, 2011.
PhD: University of Cincinnati, Cincinnati, OH, 2009.
Annette R. Lopez, MD Clinical Fellow, Division of Pulmonary Medicine 513-636-6771 firstname.lastname@example.org
Undergraduate: University of Notre Dame, South Bend, IN.
MD: University of Iowa Carver College of Medicine, Iowa City, IA.
Residency: Pediatrics, University of Arizona, Tucson, AZ.
Certification: Pediatrics, 2014.
Nadine Mokhallati, MD Pulmonary Fellow, Division of Pulmonary Medicine 513-636-6771 email@example.com
Pulmonary Fellow, Division of Pulmonary Medicine
BS: American University of Beirut, Lebanon, 2005.
MD: American University of Beirut, Lebanon, 2009.
Residency: Pediatrics, University of Arizona School of Medicine, Tucson, AZ, 2014.
Fellowship: Pediatric Pulmonary Medicine, Cincinnati Children's Hospital Medical Center, Cincinnati, OH, 2014-present.
John E. Pascoe, MD Pulmonary Fellow, Division of Pulmonary Medicine 513-636-6771 firstname.lastname@example.org
Going to medical school at UC, John Pascoe, MD, was fortunate to experience the quality of the training in both general pediatrics and the exposure to subspecialty pediatrics.
Undergraduate: University of Michigan, Ann Arbor, MI, 2006.
MD: University of Cincinnati College of Medicine, Cincinnati, OH, 2011.
Swaroop Pinto, MD Sleep Fellow, Division of Pulmonary Medicine 513-636-6771 email@example.com
MBBS: Sri Siddhartha Medical College, India, 1996.
MD Residency: Father Mullers Medical College, Mangalore, India, 2003.
MD Residency: University of Wisconsin, Madison, WI, 2013.
MD Pulmonary Fellowship: Children’s Hospital of Pittsburgh, Pittsburgh, PA, 2013-2015.
Geoffrey W. Rulong, MD Clinical Fellow, Division of Pulmonary Medicine 513-636-6771 firstname.lastname@example.org
MD: Ben-Gurion University of the Negev, Beer Sheva, Israel.
Residency: Pediatrics, Eastern Virginia Medical School, Norfolk, VA.
Certification: Pediatrics, 2013.
David R. Spielberg, MD, MHSc Clinical Fellow, Division of Pulmonary Medicine 513-636-6771 email@example.com
MD: Duke University School of Medicine, Durham, NC, 2011.
MHSc (clinical research): Duke University School of Medicine, Durham, NC, 2011.
Residency: Pediatrics, Baylor College of Medicine, Houston, TX, 2014.
Jose Torres Garcia Pulmonary Fellow, Division of Pulmonary Medicine 513-636-6771 firstname.lastname@example.org
BS: Athletic Training, East Carolina University, Greenville, NC, 2004.
MD/MHA: The Ohio State University, Columbus, OH, 2012.
Sara M. Zak, MD Clinical Fellow, Division of Pulmonary Medicine 513-636-6771 email@example.com
Marsha L. Blount, MSN, APRN, CNP Nurse Practitioner, Division of Pulmonary Medicine 513-803-0375 firstname.lastname@example.org
Nurse Practitioner, Division of Pulmonary Medicine
BSN: University of the Incarnate Word, San Antonio, Texas, 1985.
MSN: University of Texas Health Science Center, San Antonio, Texas, 1992.
CNP: University of Cincinnati, Cincinnati Ohio, 2005.
Carolyn M. Burrows, MSN, APRN, CNP, PNP Nurse Practitioner, Sleep Medicine, Division of Pulmonary Medicine 513-636-6771 email@example.com
Nurse Practitioner, Sleep Medicine, Division of Pulmonary Medicine
Sleep medicine; pulmonary management of children with neuromuscular disorders
Carolyn M. Burrows, MSN, APRN, PNP, received her Bachelor of Science in nursing from The Ohio State University in 2007 and then obtained five years of bedside, clinical nursing experience in Hematology/Oncology care at Cincinnati Children's Hospital Medical Center. She functioned in a leadership position in this department as charge nurse and chemotherapy resource nurse and worked closely with education and practice standards for the care of MIBG therapy patients. She also obtained pediatric nurse certification and pediatric advanced life support certification during this position.
She received her Master of Science in nursing from the University of Cincinnati in 2011 and began work as a pediatric nurse practitioner in sleep medicine and pulmonary management of children with neuromuscular disorders.
MSN: University of Cincinnati, Cincinnati, OH, 2011.
BSN: The Ohio State University, Columbus, OH, 2007.
Pediatric Nurse Practitioner Certification: PNCB, 2012.
Certified Pediatric Nurse: PNCB, 2012.
Craig Dailey, MSN, APRN, CNP, PNP Nurse Practitioner, Transitional Care Center, Division of Pulmonary Medicine 513-636-4459 firstname.lastname@example.org
Nurse Practitioner, Transitional Care Center, Division of Pulmonary Medicine
BSN: University of Kentucky, Lexington, KY.
MSN: Northern Kentucky University, Highland Heights, KY.
Certification: Certified Pediatric Nurse Practitioner.
Amanda F. Dressman, MSN, APRN, PNP-BC Cystic Fibrosis Nurse Practitioner, Division of Pulmonary Medicine 513-636-6771 email@example.com
Cystic Fibrosis Nurse Practitioner, Division of Pulmonary Medicine
Amanda Dressman started her nursing career as an ADN in 2001 at Cincinnati Children's. Amanda has since continued her education to obtain both a BSN, and most recently her MSN, PNP. Amanda has practiced in the role of a floor nurse, patient care facilitator, and clinical manager on the adolescent/cystic fibrosis unit.
PNP: Northern Kentucky University, Highland Heights, KY, 2009.
Certification: Pediatric Nurse Practitioner, 2009.
Jami K. Johnson, MSN, APRN, CNP, PNP Nurse Practitioner, Lung Transplant Program, Division of Pulmonary Medicine 513-803-4811 firstname.lastname@example.org
Nurse Practitioner, Lung Transplant Program, Division of Pulmonary Medicine
BSN: Houston Baptist University, Houston, TX.
MSN: University of Texas Health Science Center, Houston, TX.
Kimberly A. Kombrinck, MSN, APRN, CNP, PC/AC Advanced Practice Registered Nurse, Division of Pulmonary Medicine 513-803-3267 email@example.com
Advanced Practice Registered Nurse, Division of Pulmonary Medicine
Pulmonary/Critical Care Manager, Division of Pulmonary Medicine
AD: Cincinnati State/ Bethesda Hospital, Cincinnati, OH, 1992.
BSN: Miami University, Oxford, OH, 2005.
MSN/PNP: University of Cincinnati, Cincinnati, OH, 2007.
Janice S. MacBrair, MSN, APRN, CNP Pediatric Nurse Practitioner, Transitional Care Center, Division of Pulmonary Medicine 513-636-4459 firstname.lastname@example.org
Pediatric Nurse Practitioner, Transitional Care Center, Division of Pulmonary Medicine
MSN: Northern Kentucky University, Highland Heights, KY, 2009.
BSN: Mount Saint Joseph University, Cincinnati, OH, 1998.
BS: Microbiology, Miami University, Oxford, OH, 1985.
Carrie Martin, MSN, APRN, CNP, PNP/AC Pediatric Nurse Practitioner, Transitional Care Center, Division of Pulmonary Medicine 513-636-4459 email@example.com
State Technical and Community College, Cincinnati, OH, 2010.
of Cincinnati, Cincinnati, OH, 2011.
of Cincinnati, Cincinnati, OH, 2013.
Margaret Sutter, MSN, APRN, CNP, FNP Advanced Practice Registered Nurse, Transitional Care Center, Division of Pulmonary Medicine 513-636-4459 firstname.lastname@example.org
Advanced Practice Registered Nurse, Transitional Care Center, Division of Pulmonary Medicine
MSN: Northern Kentucky University, Highland Heights, KY, 2014.
BSN: University of Louisville, Louisville, KY, 2008.
Sarah H. Thomas, MSN, APRN, PNP-AC Pediatric Nurse Practitioner, Transitional Care Center 513-636-4459 email@example.com
Pediatric Nurse Practitioner, Transitional Care Center
Pediatric acute care; pulmonary medicine; caring for children who are chronically mechanically ventilated and have tracheostomy tubes
BSN: Morehead State University, Morehead, KY, 2006.
MSN: University of Cincinnati, Cincinnati, OH, 2012.
Certification: Acute Care Pediatric Nurse Practitioner, Pediatric Nursing Certification Board, 2012.
Tracey Van Vliet, MSN, APRN, CNP, FNP/PC Nurse Practitioner, Pulmonary Consult Team, Division of Pulmonary Medicine 513-636-6771 firstname.lastname@example.org
Nurse Practitioner, Pulmonary Consult Team, Division of Pulmonary Medicine
MSN: University of Cincinnati, Cincinnati, OH, 2013.
FNP/PC: University of Cincinnati, Cincinnati, OH, 1995.
Brittany N. Waddle, MSN, APRN, CNP, PNP Advanced Practice Registered Nurse, Transitional Care Center, Division of Pulmonary Medicine 513-636-4459 email@example.com
Specialize in providing comprehensive, coordinated care for medically complex pulmonary patients and their families. In order to achieve medical stabilization and to provide family support, provide education and resources that allow patients and families to successfully manage care at home.
BSN: Indiana University School of Nursing, Bloomington, IN, 2008.
MSN: University of Cincinnati, Cincinnati, OH, 2014.
CNP: Pediatric Nursing Certification Board, 2014.
Mark A. Washam, RRT, MSN, CNP, FNP Nurse Practitioner-APRN Inpatient, Division of Pulmonary Medicine 513-636-6771 firstname.lastname@example.org